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Objectives. To examine the clinical effectiveness of guided self-help (GSH) for 
anxiety and depression in routine clinical practice, and the role of self-efficacy, 
therapeutic alliance and socio-economic status in influencing that effectiveness. 
 
Design. A within-subjects repeated measures design in which participants served 
as their own controls by completing questionnaires across a control period prior to GSH 
intervention, then again at post-intervention and 3- and 6-month follow-up.  
 
Methods. GSH participants completed outcome measures for mental health 
(HADS) and work/social functioning (WSAS). Factors explored by regression as 
possible predictors of effectiveness were self-efficacy, therapeutic alliance and socio-
economic status.  
 
Results. Sixty people completed GSH, with analyses indicating effectiveness of 
GSH in significantly improving mental health and social functioning at post-treatment 
and 3-month follow-up, but not at 6-month follow-up. Effectiveness was also indicated 
under intent-to-treat conditions (n = 97) with medium effect sizes (≈ 0.6) for each 
outcome measure at post-treatment. Improvement in mental health was predicted by 
lower self-efficacy and greater therapeutic alliance. Completers of the intervention had 
significantly higher socio-economic status than non-completers.  
 
Conclusions. The current study has suggested effectiveness of GSH in routine clinical 
practice across different primary care services at post-treatment, but with less evidence 
of this at follow-up. Effectiveness has been highlighted to be influenced by self-efficacy 
and therapeutic alliance, suggesting the importance of considering non-specific factors 
when patients access GSH in primary care. This study underlines the need for further 
research exploring longer-term clinical effectiveness and examining for whom GSH 
works in order to constructively inform future evidence-based practice. 
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Background. CBT-based guided self-help (GSH) has been suggested to be an effective 
intervention for mild to moderate anxiety and depression, yet the evidence seems 
inconclusive, with some studies reporting that GSH is effective and others finding that 
GSH is ineffective. Guided self-help differs in important respects from other levels of 
self-help, yet the literature regarding exclusively guided self-help interventions for 
anxiety and depression has not been systematically reviewed. 
 
Method. A literature search for randomised controlled trials examining CBT-based 
guided self-help interventions for anxiety and depressive disorders was conducted. 
Multiple electronic databases were searched; several journals spanning key disciplines 
were hand-searched; reference lists of included review articles were scanned and 
relevant first authors were contacted.  
 
Results. Thirteen studies met the inclusion criteria. Meta-analysis indicated 
effectiveness of GSH at post-treatment, though GSH was found to have limited 
effectiveness at follow-up or amongst more clinically representative samples. Studies 
which reported greater effectiveness of GSH tended to be of lower methodological 
quality and generally involved participants who were self-selected rather than recruited 
via clinical referrals. 
 
Conclusions. While there is support for the effectiveness of CBT-based guided self-help 
amongst media-recruited individuals, the finding that the reviewed RCTs had limited 
                                                 
*
 As Chapter 1 is published within Psychological Medicine (Coull & Morris, 2011) it is formatted 
according to the author guidelines for that journal (see Appendix 1) 




effectiveness within routine clinical practice suggests that the current evidence is 
inconclusive. Further rigorous evidence based on clinical populations which examines 
longer-term outcomes is required before CBT-based GSH interventions can be deemed 
effective for adults accessing primary care services for treatment of anxiety and 
depression. 
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There has been a recent impetus in the UK to improve patients’ access to psychological 
therapies (Department of Health, 2005). This has been targeted through a stepped care 
model in which the intensity of intervention is matched to the severity of mental health 
symptoms. Stepped care has the potential to maximise clinical benefits from available 
therapeutic resources (Bower & Gilbody, 2005). National Institute for Clinical 
Excellence (NICE) guidelines recommend the provision of cognitive-behavioural 
therapy (CBT) based guided self-help (GSH) intervention for anxiety and depressive 
disorders as part of the stepped care approach (NICE, 2007; 2009). Despite national 
recommendations advocating guided self-help, the evidence appears inconclusive and a 
systematic review of exclusively guided self-help interventions for anxiety and 
depressive disorders has not been conducted. 
 Guided self-help can be regarded as a slightly more intensive treatment than 
‘pure’ self-help, in that it involves the support of a health professional to ‘guide’ the 
patient in the use of a self-help intervention or ‘health technology’ (e.g. a written manual 
or website). Thus, a key difference between guided self-help and non-guided self-help 
interventions is the presence of therapist input and the potential impact of therapist 
factors upon GSH effectiveness outcomes. There is considerable variability within 
guided self-help interventions in terms of: the experience and type of professional 
providing the guidance; the quantity of input provided; and the nature of the health 
technology being advocated. While effectiveness for guided self-help interventions for 
depression has been indicated in some instances (e.g. Gellatly et al. 2007), the evidence 




for effectiveness within clinical research trials or routine primary care services varies 
considerably (Khan et al. 2007). For instance, Lucock et al. (2008) describe controlled 
studies of GSH which have not demonstrated clinical benefits and highlight the minimal 
number of well-designed controlled studies of GSH, whilst Lovell et al. (2008) convey 
the lack of consensus regarding the optimal format and provision of GSH. These 
conclusions, as well as a tendency within research literature for a blurred demarcation 
between the concepts of guided self-help and non-guided self-help interventions, 
indicate the importance in specifically reviewing the clinical effectiveness of guided 
self-help for anxiety and depressive disorders. 
 Systematic reviews of research examining self-help interventions for anxiety and 
depressive disorders indicate their effectiveness (e.g. Bower et al. 2001; Morgan & 
Jorm, 2008), but temper their conclusions due to the heterogeneous mix of self-help 
interventions reviewed. Other reviews within the area have either: not been systematic 
(e.g. Newman et al. 2003); not distinguished between ‘pure’ self-help and guided self-
help (e.g. den Boer et al. 2004); or have reviewed a combination of both self-help and 
guided self-help interventions (e.g. Gellatly et al. 2007). Given: i) the ambiguity 
surrounding the effectiveness of guided self-help interventions (particularly in the 
longer-term); ii) the inherent differences between GSH and non-guided (‘pure’) self-
help; and iii) the absence of a systematic review exclusively examining the effectiveness 
of guided self-help interventions for anxiety and depression, the aim of this review was 
to systematically evaluate the clinical effectiveness of guided self-help interventions for 
anxiety and depressive disorders.  
 






The authors’ reporting within this systematic review followed guidance as outlined by 
the Centre for Reviews and Dissemination (http://www.york.ac.uk/inst/crd/) which 
forms part of the National Institute for Health Research and produces internationally 
accepted guidelines for undertaking systematic reviews.  
 




Studies were eligible for inclusion if they reported randomised controlled trials (RCTs) 
which examined guided self-help interventions in comparison to either: ‘pure’ self-help 
(i.e. interventions without therapist contact); usual psychological treatment (e.g. standard 
CBT); or waiting list control conditions. 
Population 
 
Included studies were based solely on adult participants (within the age range of 17-64) 
with anxiety or depressive disorders, regardless of gender, race or nationality. Presence 
of anxiety or depressive disorder was based upon either structured clinical interview for 
assessment of a diagnosis according to DSM-IV or ICD-10 criteria, or indicated via 
validated assessment scales adopting cut-off scores to establish clinically significant 
symptomatology (i.e. 11+ on the anxiety scale of the Hospital Anxiety and Depression 
Scale: Zigmond & Snaith, 1983; 3+ on the General Health Questionnaire: Goldberg & 
Williams, 1988; 16+ on the Center of Epidemiologic Studies – Depression scale: Bouma 
et al. 1995; or 14+ on the Beck Depression Inventory-II: Beck et al. 1996). Anxiety 
disorders included within this review are: panic disorder (with or without agoraphobia); 




generalised anxiety disorder; obsessive-compulsive disorder; social anxiety/phobia; 
phobias; and mixed anxiety disorder samples. Major depressive disorder populations 
were included in this review, whilst sub-threshold clinical depression and dysthymia 
were excluded.  
Interventions 
  
Definitions of guided self-help vary between studies; Lovell et al. (2008) refer to guided 
self-help as “involving a CBT-based self-help resource and limited support from a 
healthcare professional”, while Mead et al. (2005) describe the guided self-help model 
as an example of minimal contact where the focus is on self-help, but the therapist 
teaches effective use of the self-help resource. Guided self-help can be provided either 
by professionals (i.e. therapists with a postgraduate mental health qualification) or 
provided by para/non-professionals (i.e. therapists without a postgraduate mental health 
qualification). Inclusion of the latter group within this review is harmonious with the 
findings of a Cochrane review which indicated no difference between professionals and 
paraprofessionals in effecting change within treatment outcomes of individuals with 
anxiety and depressive disorders (Boer et al. 2005). 
  Within the present review, guided self-help is defined as an individual’s access 
to CBT-based self-help materials (e.g. books/manuals/internet) in the treatment of mild 
to moderate anxiety or depressive disorders, guided by the active support of a 
professional or paraprofessional therapist for no less than 30 minutes and no more than 
three hours in total. Studies in which therapist support consisted solely of reminders or 
assessment monitoring were excluded, as were studies which had less than a one month 




follow-up evaluation. Studies without an appropriate control condition or with 
uninterpretable findings were also excluded. 
Outcome measures 
 
Studies assessing clinical effectiveness health outcomes via validated observer and/or 
self-report measurement tools of anxiety and depression were eligible for inclusion. If 
effect sizes for primary outcome measures comparing treatment and control groups at 
post-treatment and follow-up were not documented, they were calculated using the 
formula for Cohen’s d:[(treatment mean – control mean)/pooled standard deviation]. 
 
Literature search strategies 
  
Searches were limited to studies published in English due to lack of feasibility for 
translation of texts. The literature search was initially conducted in July 2009. The 
Cochrane Database of Abstracts of Reviews of Effects (DARE) was searched to verify 
that a similar review had not recently been conducted. To ensure this initial search was 
as comprehensive as possible, DARE was searched using the more inclusive term: ‘self-
help’ as well as ‘guided self-help’ in addition to ‘depressi*’ OR ‘anxiety’. This search 
revealed only two articles loosely pertinent to the current review: firstly, a Cochrane 
protocol (i.e. not a review) of brief media-delivered interventions for psychological 
problems (Mayo-Wilson & Montgomery, 2007); and secondly, a systematic review of 
randomised and non-randomised trials of self-help, i.e. not solely RCTs and not 
exclusively examining guided self-help (Bower et al. 2001).  
 Subsequently, screening of texts was conducted by searching the following 
electronic databases: PsycINFO (1990-2009); CINAHL (1990-2009); EMBASE (1990-




2009); and Medline (1990-2009). Searches were conducted within the domains of title, 
abstract and keywords. The following search string was used within each database: 
(‘guided self-help’ OR ‘assisted self-help’ OR ‘facilitated self-help’ OR ‘supervised 
self-help’ OR ‘supported self-help’ OR ‘minimal intervention*’ OR ‘minimal contact’) 
AND (‘anxiety’ OR ‘depressi*’). These four databases were searched again using the 
same search string in May 2010 in order to account for any relevant articles published in 
the duration since July 2009 when the original literature search had been conducted. 
 Thereafter, to reduce any effect of publication bias, the first author contacted the 
primary authors of included studies and key review articles (e.g. Bower et al. 2001; 
Gellatly et al. 2007) to incorporate any unpublished studies which may meet inclusion 
criteria. Twenty-two authors were approached, of whom three could not be contacted 
and two did not respond. The seventeen responding authors suggested eighteen articles 
(both published and unpublished), but none of these met inclusion criteria for the current 
review. Additionally, relevant journals within the years of 2006 to 2009 were hand-
searched: British Journal of General Practice; British Journal of Psychiatry; and 
Psychological Medicine. The search process (as detailed in Table 1) was completed by a 
manual search of each reference list from the included articles within this review, 











Table 1. Summary of literature sources and resultant review articles 
 
Source of articles Number of potentially 
relevant articles 
initially screened for 
inclusion 
Number of articles 




CENTRAL 34 3 8, 9 & 12 
    
PsycINFO 67 4 6, 8, 9 & 11 
    
EMBASE 79 5 6, 8, 9, 11 & 12 
    
Medline 82 4 6, 8, 9 & 12 
    
CINAHL 45 3 8, 9 & 12 
    
Suggested papers after 
contacting relevant first 
authors 
18 2 6 & 13 




British Journal of 
General Practice: 9 











4 & 5 
 
8 & 10 
    
Manual search of 
reference list from 
included review articles 
 
428 4 1, 2, 3, & 7 
All sources 778 13 1 to 13 
*: Review article numbers denote articles as follows: 1: Abramowitz et al. (2009); 2: Andersson et al. (2005);  
3: Carlbring et al. (2006); 4: Carlbring et al. (2007); 5: Furmark et al. (2009); 6: Lovell et al. (2008); 7: Marks et al.  
(2004); 8: Mead et al. (2005); 9: Richards et al. (2003); 10: Salkovskis et al. (2006); 11: Schneider et al. (2005);  
12: van Boeijen et al. (2005); 13: Warmerdam et al. (2008). 
  
The titles and abstracts of the 778 potentially relevant studies were screened for initial 
assessment of their suitability according to inclusion and exclusion criteria, resulting in 
41 studies. Upon further detailed reviewing of these studies, 28 studies were excluded 
for reasons outlined in Appendix 2. The final review was based on the remaining 
thirteen studies. Figure 1 illustrates the flow of the literature review process. 






Figure 1. Flow chart detailing the literature search process 
 
Assessment of quality of included studies 
  
A recent Cochrane protocol (Mayo-Wilson & Montgomery, 2007) for media-delivered 
CBT for anxiety disorders in adults, concluded that “existing scales for measuring the 
quality of controlled trials have not been properly developed, are not well-validated and 
can give differing ratings of trial quality in systematic reviews”. They advocate the a 
priori identification of relevant quality criteria which are pertinent to the specific review 
being conducted. The Centre for Reviews and Dissemination which is part of the 
National Institute for Health Research and has published internationally accepted 
Potentially relevant studies 
screened for inclusion: 778 
Provisionally included studies:  41 




Excluded studies after reading 
article (see Appendix 2): 28 
Anxiety disorder studies: Depressive disorder 
studies: 
Anxiety and depressive 
disorder studies: 
1. Abramowitz et al. (2009) 
3. Carlbring et al. (2006) 
4. Carlbring et al. (2007) 
5. Furmark et al. (2009) 
7. Marks et al. (2004) 
11. Schneider et al. (2005) 
12. van Boeijen et al. (2005) 
8. Mead et al. (2005) 
9. Richards et al. (2003) 
2. Andersson et al. (2005) 
6. Lovell et al. (2008) 
10. Salkovskis et al. (2006) 
13. Warmerdam et al. (2008) 
Only abstract was 
accessible: 2 
 




guidance on conducting systematic reviews in health care settings (CRD, 2008) 
recommends that quality criteria should encompass an assessment of: the risk of bias; 
the choice of outcome measure; statistical issues; quality of the intervention; and 
external validity (CRD, 2008). The CRD discuss assessing the risk of bias in terms of 
rating studies’: process of randomisation; concealment of allocation; assessment of the 
similarity of groups at the study outset; reporting of the comparative level of attrition 
between groups; and use of intent-to-treat analysis. The CRD delineation of choice of 
outcome measure refers to the reliability and validity of measures therein, whilst 
statistical issues pertain to the sample size and subsequent power of the reviewed study. 
Quality of the intervention as outlined by the CRD refers to assessment of the extent to 
which the intervention was standardised and delivered as planned. Lastly, the CRD 
guide defines external validity in terms of the extent to which the study reflects how the 
intervention would be delivered within routine practice. The CRD document acted as a 
guide to limit the range of quality criteria to an optimal number which was both 
meaningful and workable to be able to draw generalisations from within a relatively 
narrow range of reviewed studies. Given consideration of the review topic, the current 
review encompasses a checklist of ten quality criteria identified a priori, which extend 
from the CRD guide to conducting systematic reviews and which encompass three 
overarching dimensions of quality criteria identified within the Delphi consensus 
(Verhagen et al., 1998) as being key: internal validity, external validity and statistical 
considerations. The list of quality criteria is outlined in full alongside Table 3.  
 The ten quality criteria were assessed in accordance with six outcome ratings as 
used by the Scottish Intercollegiate Guidance Network (SIGN) for assessing the 




methodological quality of RCTs. The first author classified each quality criterion for 
each study in terms of one of the following six outcome ratings: ‘well-covered’ (2 
points); ‘adequately addressed’ (1 point); and ‘poorly addressed’, ‘not addressed’, ‘not 
reported’ and ‘not applicable’ (all 0 points). The second author independently reviewed 
the quality of nine of the thirteen review articles, producing exact agreement on 78 per 
cent (70/90) of methodological quality ratings; the authors differed by one point (e.g. 
well-covered vs. adequately addressed) on 20 per cent (18/90) of items and by two 
points (e.g. well-covered vs. poorly addressed) on 2 per cent (2/90) of items. All criteria 




Characteristics of included studies 
 
The thirteen studies identified for the review were all randomised controlled trials. 
Seven studies evaluated the effects of guided self-help upon anxiety disorders, four 
studies focused exclusively upon depression and two studies considered both anxiety 
and depression. Effect size calculations at pre-treatment indicated no differences 
between treatment and control groups in terms of primary outcome measures. Details of 
study characteristics and key findings are outlined in Table 2.
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Guided self-help (11) 




Internet CBT + emails + 
discussion group (36) 
Discussion group control 
(n/a) 
 
Internet-guided CBT + 
weekly phone-calls (26) 







































































Self-help with minimal contact (therapist visit)  
group significantly superior to waitlist control  
group in terms of social anxiety symptoms  
at post-treatment. 
 
Internet-based therapy with minimal therapist  
contact group significantly superior to discussion  
waitlist control group at post-treatment. 
 
 
Internet-based self-help with minimal contact  
group significantly improved compared to 
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Sweden 
 










Internet-guided CBT + 
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Compared to waitlist control group, the internet- 
guided self-help group demonstrated significant  
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weekly emails (36) 








Internet-guided self-help led to significant  
improvements in social anxiety compared to  
































Guided self-help (coaches) 
(19) 















































No significant difference between guided self-help 
group and usual care group in terms of BDI scores 
at 3-month follow-up.  
 
 
Minimal contact internet-guided self-exposure was 
as effective as clinician-guided exposure therapy;  
both demonstrated significant change compared to 
relaxation control group at post-treatment. 
  
Mead 
et al. (2005) 
UK 







Assistant guided self-help 
(50) 
Waitlist control (53) 
60-120  HADS 3  Clinical   n/a 0.18 
(4.50) 
No significant difference between guided self-help 
group and waitlist control group on HADS at  
3-month follow-up.  
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Nurse guided CBT self-
help (20) 



















Nurse guided self-help was not significantly more 
effective in terms of primary outcomes than GP  
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Moderate (severe) 







GP guided self-help (38) 
GP treatment as usual 
(39) 
 




No significant differences between guided self- 
help and GP usual care at 6-month follow-up. 
 
Schneider  
et al. (2005) 
UK 




















At 1-month follow-up, improvement was  
significantly greater if self-help included exposure  
instructions versus minimal CBT excluding  
exposure. 
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Guided self-help produced as much improvement 
as less structured GP guidance in terms of  
anxiety outcomes at 9-month follow-up.  
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Internet-guided self-help was effective in  
significantly reducing depressive symptoms  
at 1-month follow-up compared to waitlist control 
group. 
ACQ: Agoraphobic Cognitions Questionnaire; BDI: Beck Depression Inventory; BSPS: Brief Social Phobia Scale;  
CES-D: Center of Epidemiological Studies – Depression; CORE: Clinical Outcomes in Routine Evaluation;  
HADS: Hospital Anxiety and Depression Scale; LSAS: Liebowitz Social Anxiety Scale; STAI: State-Trait Anxiety Inventory. 




Quality of included studies 
 
 
Table 3 provides ratings for each of the studies on the ten quality criteria. While the 
rating scale adopted does not provide an exact comparative measure across studies, it 
offers a guide to their relative methodological strengths. It suggests that Mead et al. 
(2005) and Salkovskis et al. (2006) conducted the methodologically strongest studies, 
while the majority of reviewed studies were of average quality overall. 
 As only four studies (Marks et al. 2004; Mead et al. 2005; Salkovskis et al. 
2006; Warmerdam et al. 2008) explicitly reported details regarding the validity or 
reliability of their outcome measures, the authors independently examined the 
psychometric properties for all primary outcome measures outlined across the review 
articles. All measures appeared to be valid and reliable for the relevant populations. In 
terms of the statistical variables (i.e. quality criteria: vi; vii; and viii), one study appeared 
particularly robust (Salkovskis et al. 2006). This study, along with Andersson et al. 
(2005), Mead et al. (2005) and Schneider et al. (2005) were the only ones to be 
sufficiently powered. The degree of treatment fidelity applied to interventions was not 
reported for the majority of studies, although Mead et al. (2005) and Lovell et al. (2008) 
considered the impact of such integrity upon effectiveness outcomes. 
 
 


































































































































































































































































































































































































































































































































i) The assignment of subjects to treatment groups is randomised. 
ii) An independent concealment of allocation procedure is used. 
iii) The treatment and control groups are similar at the start of the trial, with baseline scores described and differences assessed. 
iv) The only apparent difference between groups is the treatment under investigation (i.e. adequate statistical control or adjustment for confounding factors). 
v) Primary outcome measures are evidenced to be both valid and reliable and psychometric values are specified by the authors. 
vi) Levels of attrition are reported and equivalent for treatment vs. control. 
vii) Intention-to-treat (ITT) analyses are reported and missing values are imputed. 
viii) A power calculation is reported and sufficient power is achieved. 
ix) The intervention is both sufficiently defined and delivered as planned (i.e. demonstrates good fidelity). 
x) Generalisability: the trial demonstrates external validity in terms of evaluating the intervention for an appropriate duration and within a clinically-relevant setting. 




 Six studies (Marks et al. 2004; Andersson et al. 2005; Carlbring et al. 2006; 
Carlbring et al. 2007; Abramowitz et al. 2009; Furmark et al. 2009) reported large effect 
sizes demonstrating effectiveness for guided self-help relative to controls at post-
treatment. However, most of these studies were based upon media-recruited samples 
rather than samples recruited via mental health professionals and only one was 
sufficiently powered. Furthermore, the effectiveness of guided self-help relative to 
controls for these studies was typically either not reported at longer-term follow-up 
(Table 2), or indicated only a small effect size at follow-up (Furmark et al. 2009). In 
contrast, the studies which scored more highly on the methodological quality criteria 
(see the overall quality scores outlined in Table 3) tended to be based on clinical samples 
and mostly demonstrated limited or no effectiveness of GSH compared to controls, 
particularly at longer-term follow-up (ES = 0.18: Mead et al. 2005; ES = 0.03: 
Salkovskis et al. 2006). The methodologically strongest RCTs indicated that guided self-
help did not lead to improved mental health outcomes in the longer-term (e.g. three 
months or more) with respect to waitlist control or GP usual care (Mead et al. 2005; 
Salkovskis et al. 2006). 
 
Meta-analysis 
Given the wide range of effect sizes across the reviewed studies and the suggestion of 
differential effectiveness dependent upon recruitment method and reporting of outcome 
at post-treatment versus follow-up, quantitative corroboration was sought via meta-
analysis to gauge whether pooled effect sizes vary depending upon these factors. Within 
the meta-analysis, where studies reported more than one primary outcome measure, only 




the first reported primary measure was chosen to ensure that no study was over-
represented in the meta-analysis. The meta-analysis calculations were conducted by an 
external advisor who had experience of and access to software for conducting meta-
analyses. The external advisor was provided with a database of all the relevant post-
treatment and follow-up effect sizes for each reviewed study, as well as the sample size 
relevant for each calculation. The external advisor then provided the relevant output 
statistics, which were interpreted by the primary author, consisting of: weighted effect 
sizes for each study; overall weighted effect sizes; and Q-statistics indicating whether 
the extent of heterogeneity within the range of effect sizes was significantly greater than 
would be expected due to sampling variability. 
 Meta-analysis was conducted on 11 of the 13 reviewed studies reporting data 
post-intervention (Lovell et al. 2008, and Mead et al. 2005, did not report post-treatment 
data). Findings at post-treatment indicated a mean-weighted effect size of 0.69, 
suggesting considerable effectiveness of guided self-help compared to control conditions 
at post-treatment. However, seven of these 11 studies recruited participants primarily via 
media rather than clinical settings, with a mean effect size for media-recruited studies of 
1.02, compared to a mean effect size for more clinically-representative studies of 0.31. 
The Q-test of homogeneity revealed significant heterogeneity amongst effect sizes (Q = 
29.13, df = 10, p < 0.01), indicating greater variation than would be expected on the 
basis of sampling variability. Although further exploration of this heterogeneity and the 
potential effects of recruitment method would have been useful, the small N prohibited 
further detailed analysis.  




 Meta-analysis of effect sizes relating to differences between intervention and 
control groups was also conducted at follow-up and was feasible for nine of the 13 
studies. The mean weighted effect size at follow-up of 0.32 was further reduced to 0.19 
after excluding one study (Warmerdam et al. 2008) which had a low methodological 
rating and appeared to exert undue influence on the analysis. The Q-test of homogeneity 




This systematic review and meta-analysis conveys mixed findings for the effectiveness 
of guided self-help treatment for anxiety and depressive disorders. Whilst guided self-
help seems significantly more effective than waitlist control conditions if one only 
considers outcomes immediately post-treatment amongst studies where participants were 
recruited primarily via media adverts, this effectiveness is less apparent amongst 
clinically-representative samples or at follow-up. The evidenced heterogeneity at post-
treatment and apparent differences according to recruitment method suggest that the 
‘large’ effects from media-recruited studies may not generalise to clinical practice 
settings. However, three of the six more clinically-representative studies included some 
participants with severe symptoms of depression or anxiety. As guided self-help is a 
‘low intensity’ intervention intended for mild to moderate symptoms, the inclusion of 
individuals with severe symptoms may have undermined effectiveness within these 
studies. Regardless of recruitment method, the findings indicate that the extent of 
effectiveness of GSH in the longer-term is yet to be established. 




 The apparent finding that guided self-help interventions are less effective for 
patients recruited via primary care referrals compared to patients who self-select via 
media adverts is consistent with previous reviews of the depression literature (Churchill 
et al. 2002; Gellatly et al. 2007) and anxiety and depression more generally (Westen & 
Morrison, 2001). Gellatly et al. (2007) noted that the evidence base for self-help 
treatments for depression, identified within previous NICE guidelines (2004), stems 
almost exclusively from self-selected rather than clinical samples. Similarly, within the 
updated NICE guideline for depression (2009), the bulk of evidence proposed to support 
the effectiveness of GSH in reducing depressive symptoms when compared with waitlist 
control is based primarily on five studies (which were included within the 2004 NICE 
guideline as referred to by Gellatly et al. 2007) which are predominantly based upon 
self-selected rather than clinical samples. Seven of the thirteen included studies within 
the present review recruited some or all of their sample via media advertisements and 
self-selection. Such recruitment methods often rely on individuals’ motivation levels, 
which potentially corresponds to a slightly different demographic from those 
participants who are recruited within primary care settings. Most of the 
methodologically stronger studies within the current review recruited research 
participants from clinical populations and generally demonstrated weak or non-
significant effects of guided self help upon anxiety or depression, particularly where 
outcomes were considered at follow-up rather than only immediately post-treatment. 
The current findings highlight that the effectiveness of guided self-help within primary 
care settings as an effective treatment for anxiety and depressive disorders is not yet 
fully established and underlines the need for clinical recommendations to make 




reference to the potential differential impact of recruiting people via media 
advertisements versus clinical practice.  
 A further issue which contributes to the ambiguity of GSH effectiveness relates 
to the degree of treatment fidelity within the reviewed studies. With the exception of 
Lovell et al.’s (2008) study which thoroughly addressed the issue of treatment fidelity, 
the remaining studies only partially addressed treatment fidelity in terms of sufficiently 
defining the intervention and reporting that it was delivered as planned. Of the 13 
reviewed studies, only five explicitly mentioned that guided self-help therapists received 
GSH-specific training prior to applying GSH interventions. Furthermore, only six 
studies provided detail on whether therapists received supervision whilst guiding the 
intervention. Lack of detail regarding treatment fidelity, therapist training and therapist 
supervision reduces confidence in findings and generalisability of these studies – 
whether or not they endorse guided self-help as an effective intervention.   
 
 
Strengths of review 
 
The authors of this review attempted to limit the potential for publication bias by 
corresponding with authors of all included review articles, as well as authors of key 
relevant reviews in order to obtain any unpublished findings. The potential for subjective 
bias in methodological analysis was also limited by both authors independently rating 
the methodological quality of included review studies, producing a high degree of inter-








Limitations of review 
 
The current review was restricted to articles published in English, some electronic 
databases were not included within the search and a necessarily finite number of search 
terms were explored, all of which may have inadvertently excluded potentially relevant 
studies.  
 Comparing and synthesising findings across a heterogeneous mix of mental 
health problems, amounts of guidance, outcome measures and follow-up periods was not 
straightforward and led to some inherent limitations. To minimise heterogeneity, the 
current review was confined to studies which met strict inclusion and exclusion criteria, 
such as limiting included studies to those with a therapist input of no less than 30 
minutes and no more than three hours. Whilst some purported guided self-help studies 
have involved therapist input for a greater or lesser duration, for the purposes of 
definition and guided by recent relevant literature (e.g. Mead et al. 2005; Gellatly et al. 
2007), the range of 30 minutes to three hours of therapist input was interpreted to be a 
proportionate amount of input representative of a guided self-help intervention. The 
review also excluded studies in which ‘guidance’ consisted simply of assessment or 
monitoring in order to conservatively assess the effectiveness of guided self-help. Whilst 
such definitions of guided self-help introduce an element of subjective bias, this 
delineation was necessary in order to afford a greater degree of specificity and 
transparency regarding the guided self-help interventions which were reviewed. It is 
acknowledged that by attempting to increase specificity, the resultant pool of reviewed 
studies was relatively small and the meta-analysis was based on only a small number of 
studies.  





Implications for research, clinical practice and policy 
 
Currently, a wide variety of formats and duration of therapist input are all defined as 
guided self-help, such that guided self-help interventions are interchangeably – though 
perhaps not systematically – defined within a whole host of varying terminology (e.g. 
self-help, minimal contact intervention and supervised self-help). The current review 
attempted to define guided self-help as clearly as possible, as an intervention: ‘involving 
access to self-help materials in the treatment of mild to moderate anxiety or depressive 
disorders, guided by the active support (comprising more than reminders or monitoring) 
of a professional or paraprofessional therapist for no less than 30 minutes and no more 
than three hours in total’. Greater consensus regarding the definition of guided self-help 
and its distinction from non-guided self-help would facilitate future systematic 
evaluations of the effectiveness of such interventions.   
 Given the tendency within the current review for limited effectiveness of GSH at 
follow-up, amongst higher quality studies and amongst studies which recruited patients 
from clinical populations, it appears prudent to reserve judgement upon GSH 
effectiveness within clinical settings until the evidence base is substantiated by further 
high quality clinically-based research trials which examine longer-term effectiveness 
outcomes. This has implications for guideline panels and service managers. The NICE 
guidelines for depression (2009) currently recommend individual GSH for mild 
depression despite quite varied outcomes amongst studies with wide variations in terms 
of populations, recruitment, and study quality. Indeed, this heterogeneity is 
acknowledged within an appendix of those NICE guidelines, which concedes that across 




five studies indicating evidence of GSH effectiveness, there is “serious inconsistency” 
with heterogeneity greater than 50 per cent. In addition, the effectiveness referred to 
within these five studies pertains to treatment end-point, not to follow-up. Together, 
such heterogeneity and lack of follow-up – highlighted within the current review as 
differentially impacting upon GSH effectiveness outcomes – underlines the importance 
of considering such factors when assessing the evidence base for the effectiveness of 
GSH. It seems essential for future GSH studies and subsequent guidance to utilise more 
specific, consensual definitions of GSH and to reflect more fully upon issues of 
heterogeneity, recruitment and follow-up to provide greater clarity regarding the 
effectiveness of specific types of intervention for specific populations.   
 As outlined within good-practice guidance of self-help within IAPT services 
(Baguley et al. 2010): “further research is required looking at the efficacy of self-help 
both across the range of disorders and also the manner in which it might be delivered 
(e.g. guided vs. unsupported).” While such low-intensity interventions clearly need to 
offer patients choice, many GSH studies could be more rigorous in terms of 
documenting treatment fidelity and providing training/supervision for guided self-help 
therapists. The introduction by IAPT of Psychological Wellbeing Practitioners (PWPs) 
who receive training and supervision, points toward greater standardisation. There is a 
need for appropriate evaluation and dissemination of clinical GSH services to facilitate 
understanding of efficacy and predictors of outcomes within the demands of clinical 
services. This would be aided by further qualitative research to inform our understanding 
of the relevance, acceptability and key components of GSH provision from the 
perspective of patients. It is likely that certain types of GSH provided by suitably trained 




and supervised therapists would be effective for certain difficulties, but the evidence 
base does not yet provide this level of certainty. 
 It has been documented that there are “currently unrealistic assumptions about 
the proportion of patients who can benefit from guided self-help” (Lovell et al. 2008). 
More generally, Lucock et al. (2008) and Seekles et al. (2009) state the case for more 
effectiveness research within routine clinical practice in order to evaluate not only 
whether certain self-help interventions work, but crucially whether they work in clinical 
settings. The current review’s findings highlight the possibility that GSH effectiveness 
outcomes are influenced by study quality, recruitment settings and timing of outcome; 
further underlining the importance of methodological rigour in future GSH effectiveness 
research. It seems reasonable to expect that GSH can be effective in certain formats for 
certain clients. Thus GSH should remain an integral component of stepped care, but in 
the context of a research focus which is more defined, agreed and scrutinised. 
 Lovell et al. (2008) indicate that more effective targeting of guided self-help 
interventions is required, with research into predictors or moderators of treatment effect, 
due to a current lack of understanding about who benefits from guided self-help. 
Research is beginning to indicate the impact of patient factors upon self-help more 
generally (e.g. MacLeod et al. 2009). Similarly, Lucock et al. (2008) and Williams and 
Martinez (2008) acknowledge that future studies should explore the impact of non-
specific therapist factors upon self-help outcomes. While there is a suggestion that 
monitoring by the therapist is as effective as more structured guidance (Gellatly et al. 
2007), further research (particularly with regard to anxiety disorders) exploring whether 
monitoring is as beneficial as active guidance to patients will be necessary to ensure the 




provision of optimal levels of practitioner support within the low-intensity guided self-
help interventions of the stepped care model. Greater understanding of the effective 
components of GSH and of the populations who genuinely benefit from such 
interventions is necessary to appropriately inform future evidence-based use of guided 




This systematic review of the effectiveness of CBT-based guided self-help interventions 
for anxiety and depressive disorders suggests that the current reviewed evidence is 
inconclusive: guided self-help appears to be effective at post-treatment and within less 
clinically-representative populations, yet appears to be less effective within routine 
clinical settings and in the longer-term. Studies which have indicated greater 
effectiveness of CBT-based guided self-help within the current review have tended to be 
of poorer quality, have tended not to provide follow-up data and have been primarily 
based upon media-recruited participants rather than clinical samples. To ensure that 
clinical practice is informed by clinically-representative research findings and to help 
elucidate how effective guided self-help is for anxiety and depressive disorders, three 
aims for future research are suggested: i) greater consensus regarding what constitutes 
guided self-help; ii) more high quality studies which evaluate the effectiveness of well-
defined guided self-help within representative primary care samples; and iii) more 
studies which report differences between treatment and control groups not only 
immediately following intervention, but crucially at longer-term follow-up intervals.  
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2. RATIONALE FOR RESEARCH AIMS 
 
The foregoing systematic review of CBT-based guided self-help effectiveness studies 
for anxiety and depressive disorders highlighted several key findings. Firstly, the 
evidence base regarding the effectiveness of guided self-help interventions for anxiety 
and depression within clinically-representative populations remains uncertain. Secondly, 
in contrast to self-selected, media-recruited populations, there are an insufficient number 
of controlled trials examining guided self-help effectiveness within clinically-
representative, primary care settings. Thirdly, with current evidence primarily based on 
GSH effectiveness at post-treatment, there is a lack of evidence for GSH effectiveness 
outcomes in the medium or longer term. Fourthly, there remains a need to better 
understand the factors which may predict people’s success with guided self-help. The 
current study aims to focus on these four aspects of the evidence base in an attempt to 
strengthen understanding of the effectiveness of GSH within primary care and provide 
insight into factors that may influence the likelihood of improvements in patients’ 
mental health following GSH intervention.  
Given the lack of evidence for GSH effectiveness in clinical settings and beyond 
post-treatment, the current study seeks to address the first three issues above by 
examining the effectiveness of guided self-help within a routine primary care setting and 
by examining outcomes not only at post-treatment but also at three and six month 
follow-up. 
  
2.1 Factors predicting GSH outcomes 
A more detailed pretext is required for the fourth aim, regarding factors that may predict 
successful GSH outcome, as this is not covered in detail within the systematic review. 
The evidenced discrepancy in effectiveness outcomes between clinical and non-clinical 
settings suggests that GSH can be effective, but it is difficult to gauge whether effective 
outcomes in self-selected, non-clinical settings are due more to specific factors intrinsic 
to GSH (e.g. the GSH manual which is used), or to common factors (e.g. factors not 





be that these non-clinical studies are more indicative of efficacy than effectiveness, 
thereby limiting generalisability to clinical, primary care settings. Given the possible 
distinction here between evidenced efficacy in self-selected samples and a lack of 
evidence demonstrating effectiveness in clinical settings, it is worth investigating factors 
that may influence GSH effectiveness within clinical settings. It has been argued that 
much of the effectiveness seen within guided self-help may be due to non-specific 
factors (e.g. patient self-efficacy) rather than the self-help materials themselves 
(MacLeod et al., 2009). Given this lack of focus within the research field, the current 
study will investigate the role of a variety of factors that are non-specific to GSH, in 
influencing GSH effectiveness.  
 
2.1.1 Therapeutic alliance 
One common factor which exists within all interventions involving a therapist – such as 
guided self-help – is the therapeutic relationship. Therapeutic outcomes have been 
linked to the strength of the therapeutic alliance; a large meta-analysis of studies 
encompassing a variety of psychological therapies indicated an effect size of 0.22 
between therapeutic alliance and outcome (Martin et al., 2000), and some authors argue 
that most of the systematic variance in patient outcomes in psychological therapies (i.e. 
all forms of therapy; not specifically self-help or guided self-help) can be explained by 
common factors such as therapeutic alliance (Messer & Wampold, 2002). Given the 
apparent greater effectiveness of ‘guided’ versus ‘non-guided’ or ‘pure’ self-help with 
regard to depressive disorders (Gellatly et al., 2007) - where the difference is the 
presence of a therapist - it seems reasonable to assume that non-specific factors such as 
therapeutic alliance could contribute significantly to guided self-help outcomes.  
No quantitative literature currently exists on the impact of the therapeutic 
alliance on GSH outcomes for patients with depression and/or anxiety. While this may 
be due to a misconception that any therapeutic alliance in GSH is too brief to be validly 
assessed, the establishment of a positive therapeutic alliance has long been regarded as 
one of the first steps of therapy (Beck et al., 1979). Given the potential for such a 





or experiences of the therapeutic relationship could be influential in determining 
subsequent mental health outcomes, despite the patient and therapist only meeting for 
three or four appointments as is typically the case in guided self-help. Indeed, a 
qualitative synthesis of guided self-help studies suggested that the therapeutic 
relationship is fundamental in determining to what extent people engage with self-help 
materials (Khan et al., 2007). Given the potentially significant role of therapeutic 
alliance in contributing to GSH outcomes and the dearth of discussion of this within 
GSH literature, a primary objective of the current study was to quantitatively examine 
the impact of therapeutic alliance upon GSH outcomes. 
 
2.1.2 Self-efficacy 
A factor which has been evidenced to be predictive in the effectiveness of self-help more 
generally is patient self-efficacy (Mahalik & Kivlighan, 1988). Perhaps this is not 
surprising given that self-efficacy can be regarded as a source of motivation (Bandura, 
1977) and it can be classed as a construct describing a person’s belief in their ability to 
enact change through their own action in pursuit of goal attainment; two considerations 
which are liable to be intrinsic to guided self-help where the patient is required to take 
ownership of their therapeutic journey from the outset, albeit with some guidance from 
the therapist. A recent survey of mental health practitioners highlighted patient self-
efficacy as one of the variables they identified to be most predictive of successful self-
help outcomes (MacLeod et al., 2009).  
However, with specific regard to guided self-help, research examining the impact 
of patient self-efficacy upon mental health outcomes is minimal. A recent guided self-
help study found that self-efficacy was not predictive of mental health improvement 
(Hutchison, 2007). This finding was contrary to expectation given the findings of 
Mahalik and Kivlighan (1988) and the argument that greater self-efficacy would 
facilitate better engagement with self-help type interventions and thereby greater mental 
health improvement. Both studies were uncontrolled and were quite different in terms of 
therapist input, with the therapist having more input in structuring the intervention 





longer duration of intervention than that of Hutchison, which, alongside a greater onus 
on the patient, may have required greater patient motivation and therefore, necessitated a 
greater role for high self-efficacy. As such, it remains unclear to what extent patient self-
efficacy affects patient outcomes, particularly with regard to guided self-help – as 
opposed to pure or non-guided self-help – where arguably, the person does not need to 
be self-reliant to the same extent. Due to the suggested implicit role of self-efficacy for 
guided self-help and given the greater effectiveness found for guided self-help within 
media-recruited versus clinical populations – in which motivation is liable to 
differentially affect engagement and outcomes – self-efficacy was investigated here in 
an attempt to determine whether it influences mental health outcomes following GSH 
intervention.  
 
2.1.3 Socio-economic status 
As GSH is an intervention within stepped care which aims to widen access to 
psychological support, it is important to ensure that the aim to match patient demand to 
service capacity on a broad scale is informed by a sound understanding of how 
demographic factors may influence the extent to which people initially access, engage 
with and then benefit from guided self-help. Despite the enduring presence of self-help 
and guided self-help interventions within the research literature, the potential role of 
patient characteristics in determining outcomes following these interventions remains 
under-explored (MacLeod et al., 2009). A comprehensive review discussing self-help 
interventions for mental health problems acknowledged that there has been minimal 
empirical study of socio-demographic factors which may facilitate a good response to 
self-help interventions (Lewis et al., 2003). Given this lack of evidence regarding the 
influence of demographic factors on mental health outcomes, particularly with specific 
regard to guided self-help, the current study aimed to discover the extent to which such a 
factor could be predictive of GSH outcomes. 
It is well-documented that economic inequality, as indicated by lower socio-
economic status (SES), is associated with poorer mental health outcomes (Scottish 





depression have been connected with higher socio-economic status (Schmidt & Miller, 
1983). Furthermore, a large survey of CBT psychotherapists identified 46.2 per cent of 
practitioners as believing socio-economic status to be an important factor in influencing 
self-help effectiveness (MacLeod et al., 2009). There is also evidence that adults of 
lower SES rate themselves more negatively in terms of their confidence, knowledge and 
skills to enact change which would lead to health improvement and sustained resilience 
during ongoing stress (Hibbard et al., 2004). This research suggests that there is a close 
link between a person’s SES and their self-efficacy; both potentially contributing to 
ability to engage and benefit from psychotherapeutic interventions. Given the potential 
impact of lower SES in adversely impacting patients’ access, engagement and 
completion of psychotherapeutic intervention, such non-engagement or defaulting of 
treatment within a substantial demographic would conflict with the broad remit of self-
help type interventions in increasing the public’s accessibility to psychological 
interventions within the stepped care model. Therefore, the current study aims to explore 
the role of socio-economic status in determining who does or does not engage with or 





Primary care patients with mild to moderate anxiety and/or depression will show 
significant improvements in mental health and social functioning GSH outcomes at post-





Patients experiencing a greater therapeutic alliance with their therapist will benefit to a 









Patients with greater self-efficacy will benefit to a greater extent from GSH in terms of 
improvement in mental health and social functioning. 
 
Hypothesis 2c: 
Patients of higher socio-economic status will benefit to a greater extent from GSH in 
terms of improvement in mental health and social functioning. 
 
Secondary research questions: 
i) Do patients’ views correspond with their therapist’s views regarding the nature 
of their therapeutic alliance? 
ii) Do patients have fewer contacts with services regarding their mental health in the 
three-month period following the guided self-help intervention compared to the three-
month period prior to intervention? 
iii) Do patients use a lower quantity of psychotropic medication in the three-month 
period following the guided self-help intervention compared to the three-month period 



























All adult patients (aged 18 upwards) whose primary care referral had been accepted 
within three Guided Self-help services across Lothian were eligible and invited to 
participate in the research. Eligibility was assumed in that only those people whose 
referral met inclusion and exclusion criteria of the GSH services would be considered 
for participation within the research. Appropriate referrals to the service comprised: low 
mood; mild to moderate anxiety and/or depression. If upon assessment, it transpired that 
the presenting problems were too complex to be targeted by GSH, their referral was 
passed up to a higher tier within the stepped care system. 
 Of 152 people referred to Service A
∗
, 33 (21.7 per cent) provided informed 
consent and opted-in to the research. Of this number, one person was assessed to be 
inappropriate for GSH and so was excluded from the research. Eleven others defaulted 
treatment and thereby opted-out of the research, resulting in Service A data for 21 
people who completed the guided self-help intervention. Of 351 people referred to 
Service B, 61 (17.4 per cent) provided informed consent and opted-in to the research. 
Two were assessed to be inappropriate for GSH and were excluded from the study. Of 
the remaining 59, 25 subsequently defaulted treatment and thereby opted-out of the 
research, resulting in Service B data for 34 people who completed the GSH intervention. 
Of 95 people referred to Service C, 6 (6.3 per cent) provided informed consent and 
opted-in to the research. Of this number, one person subsequently defaulted treatment 
and thereby opted-out of the research, resulting in Service C data for 5 people who 
completed the GSH intervention.  
 In summary, across the three guided self-help services, 100 people (16.7 per cent 
of the total number of people referred to the GSH services) opted-in to the research, of 
whom 3 people were excluded due to being inappropriate for GSH, 37 defaulted from 
the intervention and thereby the research, while 60 completed the guided self-help 
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intervention. Figure 3.1 summarises the flow of participation and questionnaires 






In an attempt to achieve treatment control while avoiding the ethical dilemma of denying 
patients an intervention, each research participant acted as their own control by receiving 
Patients referred to GSH 
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(N = 598) 
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at 6-month follow-up  





HADS, WSAS  
Figure 3.1 Participant flow and measures administered across time 
N = 100 opted in, but 
N = 3 excluded due to 
being assessed as 





their guided self-help intervention after a slight delay. Thus, each participant who opted-
in to the study completed questionnaires approximately one month prior to beginning 
their GSH intervention. Administration of these questionnaires was repeated in the first 
session of the intervention and again – approximately one month later – during the last 
session of the intervention. Therefore, each research participant completed symptom 
measures at: one month prior to intervention (T1 in Figure 3.1); intervention start (T2); 
and intervention end (T3). This design was adopted to provide control (i.e. T2 - T1) versus 
intervention (i.e. T3 - T2) periods which were comparable in order to control for any 
change in symptoms which may have happened spontaneously, irrespective of GSH 
intervention. If improvement in symptomatology across the intervention period was 
significantly greater than improvement across the control period, this would provide 
greater assurance that any mental health gains were due to intervention rather than 
spontaneous recovery. Thus, a within-subject design in which participants served as their 
own controls was used to examine any change in mental health or social functioning for 




Data were collected from patients within Service A between June 2009 and June 2011, 
within Service B between July 2010 and June 2011, and within Service C between 
January 2011 and June 2011. 
  All patients who met the inclusion criteria for the GSH service were sent 
information about the GSH service before being sent opt-in research questionnaire packs 
the following day. This opt-in pack consisted of a research information sheet (see 
Appendix 3) as well as a consent form (see Appendix 4) and baseline questionnaires 
comprising HADS, WSAS, GSES, NS-SEC (see Appendixes 5-8 as well as section 3.4 
for psychometric details), to be returned in an enclosed, stamped, addressed envelope. If 
the consent form and questionnaires were not returned within approximately two weeks, 
it was assumed that that person had decided not to opt-in to the study. For ethical 






 For those people who did opt-in to the study, the date they completed the 
questionnaires (indicated on their returned consent form) signified the start of the control 
period. Where possible, a one-month control period was sought before the first session 
of the guided self-help intervention. The lead researcher received the initial opt-in 
questionnaires, while the GSH therapists administered the questionnaires within the first 
and last GSH sessions. Within the first session, the GSH therapist administered the 
HADS, WSAS and GSES at the beginning of the session. The participant was also asked 
to complete a brief, non-validated mental health utilisation (MHU) questionnaire 
consisting of four questions (see Appendix 9) regarding their prescription of 
psychotropic medication and consultation with GPs and other mental health 
professionals within the preceding three-month period. At the end of the first session, 
both the research participant and therapist completed their respective versions of the 
Working Alliance Inventory – Short version (WAI-s; Tracey & Kokotovic, 1989). In an 
attempt to obtain a fair representation of any alliance between therapist and patient, both 
parties were requested to complete this questionnaire in the absence of the other. To 
facilitate further data integrity, the patient was asked to seal - prior to the return of the 
therapist - their completed WAI-s in an envelope which was marked: “Private and 
confidential; only accessible to the lead researcher.”  
 At the end of the final session of the intervention the GSH therapist again 
administered the HADS, WSAS and GSES. Again, the GSH therapist and patient 
completed their respective versions of the WAI-s. Finally, in order to examine any 
longer-term impact of GSH upon mental health and social functioning, the lead 
researcher sent the HADS and WSAS (as well as a stamped, addressed envelope) to 
research participants at follow-up intervals of three and six months subsequent to their 
final session of GSH intervention. At the three-month follow-up stage, participants were 
also sent the MHU questionnaire in order to ascertain the person’s usage of psychotropic 
medication and GP consultations within the three-month period subsequent to their GSH 
intervention. If these follow-up questionnaires were not returned to the lead researcher, a 
reminder letter was sent - along with further copies of the questionnaires and stamped, 





the return of the questionnaires, it was assumed that that person had opted-out of the 




3.4.1 Therapeutic alliance  
  
The 12-item Working Alliance Inventory (WAI-s; Tracey & Kokotovic, 1989) derives 
from the 36-item original version (WAI; Horvath & Greenberg, 1989). The WAI is one 
of the most frequently used and well-validated questionnaires assessing therapeutic 
alliance (Knaevelsrud & Maercker, 2006; Spinhoven et al., 2007). The original version 
has been shown to be reliable and valid and to correlate highly with other measures of 
therapeutic alliance (Summers & Barber, 2001). The WAI-s has been evidenced to have 
high interchangeability with the psychometric and predictive qualities of the full version 
of the form (Busseri & Tyler, 2003) and was included in the proposed research due to its 
brevity and capacity to capture both patient and therapist perspectives regarding their 
therapeutic alliance. There is strong evidence for both concurrent and predictive validity 
of the WAI-s (Tracey & Kokotovic, 1989). In a review of WAI-s studies, the WAI-s has 
been shown to have high internal consistency for the patient (.95) and therapist (.93) 
version, as well as high reliability for the patient (.97) and therapist (.92) version 
(Hanson et al., 2002).  
 The WAI-s is a self-report questionnaire, with patient and therapist versions, 
comprising three subscales which encompass three aspects of the therapeutic alliance. 
The level of agreement and engagement between the patient and therapist is assessed in 
terms of: the treatment goals; how to achieve the treatment goals; and the extent of 
acceptance, trust and confidence between the patient and therapist. Respondents are 
asked to rate each question on a 7-point Likert scale ranging from 1 (never) to 7 
(always). A composite score (minimum: 12; maximum: 84) is used to provide a measure 








3.4.2 Self-efficacy  
 
Given the lack of a self-efficacy measure specific to mental health, the 10-item 
Generalised Self-Efficacy Scale (GSES; Schwarzer & Jerusalem, 1995) was chosen to 
provide an indication of the participant’s perceived ability to respond to difficult and 
emotional situations primarily by seeing the self as the agent of change. This scale is 
sufficiently broad to capture self-efficacy as a broad concept in predicting quality of life, 
well-being and health outcomes (Schwarzer & Hallum, 2008). In terms of psychometric 
properties, initial evaluations within German populations indicated high internal 
consistency (Schwarzer & Jerusalem, 1995). Subsequently, high validity and reliability 
have been reported across ethnically diverse samples and a range of research contexts 
(Luszczynska, Scholz et al., 2005). Factor analyses has indicated that the GSES forms 
one global dimension (Leganger et al., 2000) and the construct of self-efficacy has high 
convergent validity as indicated by significant correlations between GSES scores and 
factors synonymous with ‘active coping’ (Luszczynska, Scholz et al., 2005). 
Furthermore, significant inverse relationships have been identified between GSES scores 
and anxiety and depression (Leganger et al., 2000) while positive correlations have been 
evidenced between GSES scores and optimism (Luszczynska, Gutiérrez-Doña et al., 
2005).     
 Participants respond to the GSES across 10 items (e.g. “I can remain calm when 
facing difficulties because I can rely on my coping abilities.”) within a range of four 
responses from: (1) not at all true to (4) exactly true, culminating in a score ranging 
between 10 and 40 (higher scores indicating greater perceived self-efficacy). 
 
3.4.3 Socio-economic status  
 
Since 2001, socio-economic status has been indicated by a classification system based 
on a person’s level of occupation (ONS, 2005). The occupation-derived National 
Statistics Socio-economic Classification (NS-SEC) system provides a contemporary 
representation of a person’s socio-economic status and assigns people to social classes 





It has been evidenced to have both criterion and construct validity, and is recommended 
for use as a standardised tool within research (Rose et al., 2005). This tool has been used 
to examine socio-economic classification within guided self-help research similar to the 
current study (Mead et al., 2005). A self-coded questionnaire version of NS-SEC exists 
which can be used in postal surveys (i.e. appropriate for the current study) and sub-
classifies a person’s status into one of five categories: managerial and professional 
occupations; intermediate occupations; small employers and own account workers; 
lower supervisory and technical occupations; and semi-routine and routine occupations. 
Based upon respondents’ responses to four questions, it is possible to use this 
information to derive a classification of socio-economic status. 
 
3.4.4 Mental health symptomatology  
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) is a well-
validated measure which provides an indication of the severity of symptoms of anxiety 
and depression. It has been evidenced to have high reliability and validity, with high 
internal consistency for the anxiety scale of .80 (Mykletun et al., 2001) and the 
depression scale of .84 (Cameron et al., 2008). It was used in this research due to: its 
brevity; its exclusion of somatic-based items which may otherwise artificially inflate 
scores; its wide use within primary care research; and its routine use within the services 
being researched.  
 The HADS consists of 14 self-report items: 7 anxiety and 7 depression symptom 
items, all of which are rated on a four-point Likert scale. Respondents are asked to rate 
their symptomatology within the preceding week, across four responses typically 
ranging from: (0) not at all to (3) very often. Within the anxiety and depression 
subscales, each has a possible total score of 21, with scores of 11 and above being 
indicative of clinically significant symptomatology. 
 
3.4.5 Work and social functioning  
 
The Work and Social Adjustment Scale (WSAS; Mundt et al., 2002) is a short, reliable 





consistency ≥ .80, convergent validity with depressive symptoms of .76, and good test-
retest reliability (.73) (Mundt et al., 2002). Furthermore, the Improving Access to 
Psychological Therapies document (DoH, 2008) lists the WSAS within its ‘Outcomes 
Toolkit’ and recommends it as an outcome measure to implement within primary care 
outcome research.  
 Participants respond to the WSAS across five items relating to the domains of: 
work; home management; social leisure activities; private leisure activities; and family 
and relationships. Each item ranges from (0) no impairment at all to (8) very severe 
impairment, with high overall scale scores (maximum: 40) indicating greater functional 
impairment.  
 
3.4.6 Mental health service utilisation  
 
In order to further understand the effectiveness of guided self-help within the stepped 
care system, it was important to measure the impact of the intervention not only on the 
patient, but also on the wider health system surrounding the patient. In an attempt to 
gauge this service consumption, measurements were taken of participants’ type and 
dosage of psychotropic medication prescribed (if any) and number of consultations with 
their GP and/or other mental health professional. A similar study conducted by Mead et 
al. (2005) measured these variables via self-report by research participants. This method 
of measurement was adopted in the current research by virtue of the mental health 
service utilisation (MHU) questionnaire consisting of four questions relating to 
participants’ use of psychotropic medication and frequency of appointments with GPs or 
other professionals regarding their mental health within the preceding three-month 
period. Although this method provides ecological validity, there is a risk of losing 
valuable information due to the potential for social desirability in participants’ 
responding or a memory lapse within participants’ subjective recall. This risk was 
countered by attempting to assess participants’ health service utilisation not only via 
subjective recall, but by objectively examining patient electronic records of the same 
information held within GP practices. It was anticipated that measuring participants’ 





the impact of GSH intervention upon these variables than by solely asking participants 
to recall this information. Consultations between the patient and their GP (whether face-
to-face or via telephone) were classed as a mental health consultation if the GP record 
for that consultation noted the patient’s mental health issue exclusively or primarily, 
relative to any record of non-mental health issues.  
 
3.5 GSH service characteristics 
Participants were recruited from three different guided self-help services. These services 
received GSH referrals within primary care settings, either directly from general 
practitioners or via triage meetings. All services provided GSH intervention to adults 
with anxiety or depressive disorders, consisting of the therapist guiding the patient via 
written CBT-based self-help manuals. With regard to intervention for depressive 
problems, all services used the ‘Overcoming Depression’ (Williams, 2006) self-help 
resource. With regard to intervention for anxiety problems, GSH Services B and C 
typically used the ‘Overcoming Anxiety’ (Williams, 2003) self-help resource, while 
Service A used the ‘How to Manage Anxiety’ (Stuckey & Millar, 2003) self-help 
resource. Therapists within all three services guided patients using these self-help 
resources across no more than four sessions, depending on patient need, with each 
session typically lasting between 30 and 45 minutes.  
 Within Service B, four GSH therapists were employed concurrently to provide 
GSH interventions, compared to one GSH therapist employed in both Service A and C. 
Across the duration of data collection, the five therapists within Services B and C 
remained constant, while Service A consisted sequentially of three different therapists. 
All eight therapists had at least an undergraduate degree in psychology, with three 
educated to postgraduate level. In terms of professional qualifications, one GSH 
therapist had an MSc in Psychological Therapy in Primary Care, one therapist had a Post 
Graduate Certificate in Primary Care Mental Health, and one therapist had a Diploma in 
Counselling. Within services B and C, all therapists were designated ‘guided self-help 
workers’, while GSH Service A was provided by assistant psychologists. With regard to 





(i.e. encompassing the basics of CBT and the self-help manuals which were used) via 
psychologists working in clinical practice. Similarly, across the three services, all 
therapists received clinical supervision at least fortnightly from a practising 
psychologist, and a selection of guided self-help sessions were recorded and reviewed by 
supervisors to ensure treatment fidelity.  
 
3.6 Ethical considerations 
 
Ethical approval was given by the University of Edinburgh Ethics Committee. Ethical 
opinion was sought from the South East Scotland Research Ethics Service who 
classified the study as a service evaluation and thus did not require ethical panel review 
(see Appendix 10). Approval was also obtained from NHS Lothian Research and 
Development department and the Caldicott Guardian (see Appendixes 11 to 12).  
 One ethical consideration was participants’ (and therapists’) method of 
responding to the therapeutic alliance questionnaire (WAI-s). As this questionnaire 
sought to obtain patient and therapist perspectives upon the presence (or lack thereof) of 
any therapeutic alliance, in order to reduce the risk of receiving inflated responses 
through pressure to appear overtly harmonious, therapists were instructed to ensure that 
the patient and therapist both completed their respective version of the WAI-s in the 
absence of the other. Therefore, where possible, the therapist would briefly leave the 
patient in the clinic room so that both therapist and patient could complete the form 
independently of the other. Before temporarily leaving the clinic room, the therapist also 
asked the patient to seal their completed WAI-s within an envelope prior to the therapist 
returning. This envelope was marked: “Private and confidential: only accessible to the 
Lead Researcher.” to emphasise to participants that their WAI-s responses would not be 
accessible to their therapist. These steps were taken in anticipation that patients (and 
therapists) could respond more truthfully and openly than may otherwise have been the 
case in the overt presence of the other member of the alliance.  
 Given the extensive questionnaire battery which participants were asked to 
complete across the duration of the research, questionnaires (where reliable and valid) 





indicated that 20 minutes would generally be a sufficient amount of time to complete the 
five measures) to ensure that the estimated time for completion outlined within the 
research information form was generally accurate. Piloting also indicated that it was 
likely that the ‘Therapist’ version of the WAI-s would take two to three minutes for 
therapists to complete.  
 Given the potential for participants to report significant distress during their GSH 
intervention, which would give cause for concern that GSH would not be a sufficiently 
intensive intervention for that person’s needs, all GSH therapists were regularly 
supervised and could discuss such concerns with a qualified psychologist to ensure 
appropriate next steps. If such a discussion led to a research participant receiving a 
different intervention, then, by discontinuation of the GSH intervention, that research 
participant would take no further part in the research. Similarly, participants were 
reminded within the research information provided prior to consenting to the study that 
they could withdraw their participation at any point without a need for explanation and 
with no adverse consequences for their subsequent provision of psychological care. 
 
3.7 Power analyses and statistical analyses 
 
In order to detect differences between the intervention and control phases, with α = .05 
and a power value of .80, published power tables (Cohen, 1992) indicated that based on 
a medium effect size between two groups, a sample size would be required of n = 64. A 
medium effect size (around d = 0.4) was selected as an approximate average of the effect 
sizes of similar studies or meta-analyses, ranging from 0.19 (Mead et al., 2005) and 0.27 
(Lucock et al., 2008) to 0.8 (Gellatly et al., 2007). With regard to the second hypothesis 
and which variables predict mental health or social functioning GSH outcomes, to detect 
a medium effect size (f² = 0.15) in multiple regression analyses with three predictor 
variables, with α = .05 and power at .80, published power tables (Cohen, 1992) indicated 
that the required sample size would be 76 participants. Where necessary sample sizes 
were not achieved, post-hoc power calculations were conducted using an online 





 To examine any changes between pre-and post-intervention mental health 
symptoms, frequency of mental-health based consultations and psychotropic medication 
quantities, paired-samples t-tests were used. Also, to incorporate non-completers of the 
intervention into analysis and to conservatively assess GSH effectiveness, intent-to-treat 
analyses were conducted using the last-observation-carried-forward (LOCF) technique. 
This technique carries forward pre-intervention scores to replace any missing values for 
outcome measures at post-intervention and has been used in similar GSH primary care 
research (e.g. Richards et al., 2003; van Boeijen et al., 2005).  
 Multiple regression analyses were used to explore the relative contribution of 
therapeutic alliance, patient self-efficacy and socio-economic status upon mental health 
and social functioning outcomes. Finally, to examine any correspondence between 
patients’ and therapists’ ratings of the therapeutic alliance, correlational analyses were 
used. Similarly, correlational analysis was applied to examine any correspondence 
between patients’ subjective recall and GP records of mental health contact and 





















4.1 Journal article results 
4.1.1 General and demographic information  
Of 598 people invited to participate, 100 (16.7 per cent) opted-in, three of whom were 
excluded as they were subsequently assessed to be inappropriate for GSH. Of the 97 
people remaining, 72 (74.2 per cent) were female and ages ranged from 19 to 76 (M = 
36.8; SD = 12.5). Of these 97 participants, 37 (38 per cent) defaulted treatment: 20 
dropped out prior to the first GSH session and 17 defaulted after attending the first GSH 
session but prior to the final session. The remaining 60 participants completed the GSH 
intervention; 42 (70 per cent) of whom were female and ages ranged from 20 to 76 (M = 
37.2; SD = 12.3). Thirty-two presented primarily with anxiety-related problems, while 
the remainder presented with depressive-related problems. Twenty-five participants 
received their GSH intervention across three sessions, while 35 received their 
intervention across four sessions. The mean duration of the baseline control period was 
26.3 days (SD = 23.9) and 59.6 days (SD = 29.8) for the intervention period. At the time 
of analysis, 3-month and 6-month follow-up data were available for 25 and 16 
participants respectively. 
 
4.1.2 Effectiveness of GSH for anxiety and depression 
The mean outcome scores for completers on the HADS and WSAS across the five time-
points: pre-intervention (T1); intervention-start (T2); intervention-end (T3); 3-month 
follow-up (T4); and 6-month follow-up (T5), are displayed in Table 4.1. Values were not 
imputed for missing data (e.g. where a questionnaire had mistakenly been overlooked by 
a participant); rather, to conservatively assess effectiveness and ensure transparency 
across the time-points, data were only analysed for each participant where measurements 








Table 4.1      Anxiety, depression and functioning outcomes across time 
 HADS - Anxiety HADS - Depression WSAS 
 M SD n M SD n M SD n 
          
Pre (T1) 12.42 3.05   57* 8.16 3.83 57 19.64 7.01    44** 
          
Start (T2) 11.88 3.71 57 7.93 3.80 57 19.84 7.32 44 
          
End (T3)   8.19 3.28 57 4.74 3.00 57 14.77 7.78 44 
          
3-month (T4)    8.16 4.31 25 4.24 2.95 25 13.57 8.02 21 
          
6-month (T5)   9.44 3.37 16 5.06 3.55 16 14.00 7.92 14 
* Not complete HADS data across T1, T2, and T3 for n = 3, so removed from analysis.  
** Not complete WSAS data across T1, T2, and T3 for n = 16, so removed from analysis. 
 
 To ascertain whether these apparent improvements in mental health and social 
functioning across intervention and follow-up were significant compared to the control 
period, analyses examined whether symptom improvement by intervention-end (i.e. T3 – 
T2), 3-month (i.e. T4 – T2) and 6-month follow-up (i.e. T5 – T2) was significantly greater 
than any spontaneous improvement across the control period (i.e. T2 – T1). Therefore, 
paired t-tests were conducted to compare the degree of improvement by intervention-
end, 3-month and 6-month follow-up to any degree of improvement across the control 
period (e.g. T3 – T2 versus T2 – T1). Table 4.2 displays the t and p values, as well as the 
effect size (Cohen’s d) for each comparison. Across all three outcome measures, 
participants’ outcomes improved significantly between the start and end of GSH 
intervention relative to the control period. Post-hoc power calculations at intervention-
end indicated power of 0.92, 0.90 and 0.68 for anxiety, depression and social 
functioning improvement respectively. These significant improvements relative to the 
control period were maintained at 3-month follow-up, though the post-hoc power values 
across the three outcome measures ranged from 0.41 to 0.70. Despite a small sample size 
at 6-month follow-up, improvement in work and social functioning was also maintained 






Table 4.2 Improvement in anxiety, depression and functioning across the 
intervention and follow-up compared to the control period 
 Intervention-end 
versus control period 
3-month follow-up 
versus control period 
6-month follow-up 
versus control period 
 










n = 57 
t = 4.20 
p < .01 
d = 0.91 
 
n = 57 
t = 4.22 
p < .01 
d = 0.88 
 
n = 44 
t = 3.19 
p < .01 
d = 0.75 
 
n = 25 
t = 3.20 
p < .01 
d = 1.04 
 
n = 25 
t = 2.62 
p = .02 
d = 0.74 
 
n = 21 
t = 2.67 
p = .02 
d = 0.80 
n = 16 
t = 1.99 
p = .07 
d = 0.83 
 
n = 16 
t = 1.75 
p = .10 
d = 0.74 
 
n = 14 
t = 2.50 
p = .03 
d = 0.92 
 
  
To conservatively assess GSH effectiveness as indicated above, intent-to-treat 
(ITT) analysis using the last-observation-carried-forward (LOCF) technique was used to 
include those people who opted-in to the research but did not complete the GSH 
intervention. Therefore, for those people who defaulted GSH (n = 37), all pre-
intervention or intervention-start scores were carried forward to post-intervention. 
Similarly, for those completers who had missing data (e.g. where a questionnaire had 
been mistakenly overlooked by the participant), LOCF was used to include these 
participants in the analysis. ITT analysis was based on 97 people (60 completers and 37 
non-completers). Since the small sample size at follow-up would have resulted in ITT 
analyses at follow-up being based on estimation for the vast majority (74 per cent) of 
cases and therefore less meaningful, ITT analyses were conducted on post-intervention 










Table 4.3 Anxiety, depression and functioning outcomes across time under ITT  
 HADS – Anxiety 
        (N = 97) 
HADS – Depression 
        (N = 97) 
      WSAS  
       (N = 91*) 
 M SD  M SD  M SD  
          
Pre (T1) 12.16 3.20  7.79 3.80  18.69 7.66  
          
Start (T2) 11.73 3.51  7.60 3.78  18.70 8.35  
          
End (T3)   9.41 3.71  5.65 3.54  15.47 8.67  
*N = 6 did not have WSAS data at pre-intervention or intervention start so could not be included via last-
observation-carried-forward technique. 
 
As Table 4.3 conveys, under ITT, the mean scores for all three outcomes at 
intervention-end (T3) were still improved compared to intervention-start (T2). To 
determine whether this improvement by post-intervention was significant compared to 
any spontaneous improvement across the control period, paired t-tests were conducted as 
displayed in Table 4.4. 
  
Table 4.4 ITT analysis of improvement in anxiety, depression and functioning 
across the intervention compared to the control period 
  Control Intervention    




0.43 2.04 2.32 3.72 3.91 < .01 0.63 
HADS - 
Depression 
0.19 2.05 1.95 3.49 3.94 < .01 0.61 
Work/Social 
functioning 
-0.01 4.58 3.23 6.80 3.52 < .01 0.56 
  
The ITT analyses illustrate that even conservatively using the last-observation-
carried-forward technique to accommodate missing data, significant improvements in 
mental health and social functioning occurred across the duration of the intervention 





conditions, mental health and social functioning outcomes are significantly improved at 
post-intervention.  
 
4.1.3 Clinically significant change on HADS  
As HADS subscale scores ≥ 11 typically indicate clinically significant symptomatology, 
the data of the 60 completers were examined to gauge what proportion of individuals 
experienced a clinically significant change in their symptoms. Of 38 people with 
clinically significant symptoms of anxiety at the start of GSH, 27 (71 per cent) no longer 
had clinically significant symptoms by the end of GSH intervention. Six of 15 (40 per 
cent) people no longer had clinically significant symptomatology by 3-month follow-up, 
while 6 of 9 (67 per cent) continued to enjoy clinically significant improved anxiety 
symptoms at six months. Of 7 people with clinically significant symptoms of depression 
at the start of GSH, 6 (86 per cent) no longer had clinically significant symptoms by 
intervention-end.  
 
4.1.4 Factors influencing mental health and social functioning outcomes 
As indicated previously, improvements in mental health (HADS) and social functioning 
(WSAS) were represented by calculating the difference in outcome scores between 
intervention start and end (i.e. T3 – T2). For the completer sample only, correlation and 
regression analyses were conducted to explore any relationships between these 
‘improvement scores’ in mental health and social functioning, and self-efficacy, 
therapeutic alliance and socio-economic status. Significant correlations were found in 
the following instances: HADS (anxiety) improvement by intervention-end was 
inversely correlated with patient self-efficacy in the first GSH session (r = -.39, p < .01), 
positively correlated with patient self-efficacy in the final session (r = .36, p < .01), and 
positively correlated with patients’ perception of the therapeutic alliance in the first 
session (r = .27, p < .05). HADS (depression) improvement by intervention-end was 
inversely correlated with patient self-efficacy in the first session (r = -.34, p = .01) and 





session (r = .29, p < .03). Improvement in social functioning was not correlated with 
self-efficacy, therapeutic alliance or socio-economic status. 
 Multiple regression analyses were conducted to further examine the relationships 
indicated by correlation analysis. Thus, for a regression model with improvement in 
anxiety by intervention-end as the outcome measure, three predictor variables (patient 
self-efficacy in first session; patient self-efficacy in final session; therapeutic alliance in 
first session) were entered into a stepwise regression analysis. The regression model was 
significantly predictive of outcome: F(2, 50) = 23.68, p < .01, explaining 48.6 per cent 
of variance in anxiety improvement. Two variables emerged as significant predictors: 
low patient self-efficacy as rated in the first GSH session (β = -.66, t = 5.89, p < .01) and 
high patient self-efficacy as rated in the final GSH session (β = .63, t = 5.69, p < .01). 
Collinearity statistics indicated that these two predictors loaded on to different 
dimensions, indicating that there was no presence of multicollinearity in the regression 
model. A post-hoc power calculation indicated that this regression model had a power 
value of 0.99 (α = 0.05, two predictor variables, R² = 0.49).  
 Regarding improvement in depressive symptoms by intervention-end, as guided 
by correlation analysis, patient self-efficacy in the first session and therapeutic alliance 
in the final session were entered into a stepwise regression analysis. The regression 
model was significantly predictive of outcome: F(2, 51) = 6.40, p < .01, explaining 20.1 
per cent of variance in depression improvement. Two variables emerged as significant 
predictors: therapeutic alliance as rated by the therapist in the final session (β = .30, t = 
2.37, p = .02) and low patient self-efficacy in the first GSH session (β = -.29, t = -2.30, p 
= .03). Again, collinearity statistics highlighted that these two predictors loaded on to 
different dimensions, indicating that there was no presence of multicollinearity in the 
regression model. A post-hoc power calculation indicated that this regression model had 









4.2 Additional results   
4.2.1 Normality  
Kolmogorov-Smirnov statistics and normal Q-Q plots indicated some deviation from 
normality within the intent-to-treat dataset for a minority of outcome variables (i.e. 
improvements in anxiety, depression, and social functioning) where due to last 
observations being carried forward, there were no differences between symptoms at start 
and end of the intervention for non-completers; i.e. multiple data-points had a value of 0. 
Nonetheless, non-parametric analyses (e.g. Wilcoxon Signed-Rank tests and Spearman’s 
rho) were conducted as a conservative equivalent to confirm that parametric analyses 
were not unduly influenced by any non-normality.  
 
4.2.2 The role of therapeutic alliance in GSH  
 
Secondary research question i): Do patients’ views correspond with therapists’ views 
regarding the nature of their therapeutic alliance? 
Pearson correlations were analysed to examine whether patients’ views corresponded 
with therapists’ views regarding the nature of their therapeutic alliance. As Table 4.5 
indicates, patients’ and therapists’ views regarding the therapeutic alliance were not 
significantly correlated in the first GSH session, but they were significantly correlated 
within the final GSH appointment. Akin to the significant correlation between patients’ 
views on the therapeutic alliance in the first and last appointments, therapists’ views on 













Table 4.5 Correspondence between patients’ and therapists’ ratings of the 
therapeutic alliance  
















r =  .03 
p = .82 
 
r =  .42 
p < .01 
 
r =  .13 





r =  .13 
p = .36 
 
r =  .26 







r =  .45 
p < .01 
  
A univariate (2 x 2) ANOVA was conducted to explore the impact of time (intervention 
start versus intervention end) and grouping (patient versus therapist) on rated therapeutic 
alliance. Both grouping and time were found to be significantly related to mean 
therapeutic alliance ratings: Group, F(1) = 20.72, p < .01; Time, F(1) = 15.11, p < .01. 
As depicted graphically in Figure 4.1, the interaction between group and time was not 






Figure 4.1 Therapeutic alliance as rated by patients and therapists across time 
 
 Finally, with regard to the apparent discrepancy between patients’ and therapists’ 
ratings of the therapeutic alliance, correlations were examined to determine whether the 
discrepancy between therapist and patient ratings in the first GSH session or in the last 
session was related to any improvement in mental health or social functioning by the end 
of intervention. No significant correlations were identified between the discrepancies in 
therapeutic alliance ratings and mental health or social functioning improvement (all p > 









4.2.3 The wider impact of GSH on primary care services 
 
Secondary research question ii): Do patients have fewer contacts with services regarding 
their mental health and use a lower quantity of psychotropic medication in the three-
month period following the guided self-help intervention compared to the three month 
period prior to intervention? 
 
3-month follow-up data regarding patients’ frequency of mental health consultations 
with GPs or other mental health professionals was obtained for 26 of the 60 completers. 
In the 3-month period preceding the GSH intervention, patients visited their GP 
regarding their mental health problems on a mean number of 2.96 occasions (SD = 2.36) 
and other professionals (e.g. counsellor, community psychiatric nurse, psychiatrist) on a 
mean number of 0.29 occasions (SD = 0.90). In contrast, in the 3-month period 
following GSH intervention, patients visited their GP regarding their mental health on a 
mean number of 0.92 occasions (SD = 1.20) and other professionals on a mean number 
of 1.10 occasions (SD = 3.06). These contrasts are depicted graphically in Figure 4.2. 
The difference in the mean frequency of patients’ consultations with their GP before and 
after GSH intervention was statistically significant: t(25) = 4.29, p < .01, while the 
corresponding difference between time periods with regard to consultation with other 






Figure 4.2 Completers’ consultations regarding their mental health 
  
 With regard to the prescription of psychotropic medication, 9 of the 26 
participants were not prescribed medication in either of the 3-month periods. Within the 
remaining 17 patients, 10 remained on the same type and dosage of medication (e.g. 
citalopram, fluoxetine, etc.) in the 3-month period following GSH intervention as was 
received in the 3-month period preceding the intervention; 6 people received a lower 
quantity of psychotropic medication following GSH intervention; and the remaining 









4.2.4 Differences between GSH completers and non-completers 
An independent samples t-test was used to examine any differences in baseline scores 
between those who completed the intervention (n = 60) and those who defaulted from 
GSH prior to completing the intervention (n = 37). The array of variables for the two 
groups with corresponding means, standard deviations, t and p-values are outlined in 
Table 4.6. As can be seen, only one variable, socio-economic status (t = -2.05, p < .05), 
significantly (albeit marginally) distinguished those who completed the intervention 
from those who defaulted the intervention. Specifically, completers had a significantly 
higher socio-economic classification, indicating they were more likely to have 
managerial or professional occupations, whereas non-completers were typically more 
likely to have routine or technical occupations.  
 




(n = 60) 
        Non-completers 
        (n = 37) 
 






 p   M        SD            M             SD 
Age 37.15 12.27     36.11          12.91  0.39 .70 
SES   1.62        1.10              2.33            1.62  2.05 .047 
HADS-A (Pre) 12.30        3.12            11.95           3.35  0.53 .60 
HADS-D (Pre)   8.03        3.81              7.38           3.79  0.82 .41 
WSAS (Pre) 19.26        7.93            17.70           7.16  0.94 .35 
GSES (Pre) 24.67        5.63            24.43           5.74  0.20 .84 
Therapeutic alliance  
(Patient) 







     11.83 
 
           65.35
 






4.2.5 Differences in mental health and social functioning between GSH services 
To check that the GSH intervention received between services was equitable in terms of 
effectiveness, two of the three services were compared to examine if there were any 
differences in the extent of improvement in mental health and social functioning. At the 





Independent samples t-tests were used to analyse the differences between the other two 
services (A, n = 21; B, n = 34) and these data are outlined in Table 4.7. As conveyed in 
Table 4.7, the services did not differ significantly in terms of the improvements observed 
across any of the outcome measures. 
  
Table 4.7 Differences in improvement between two GSH services 
Outcome measure 
 
Service A Service B  
t 
 
M SD M SD p 
 
HADS – Anxiety  
(By end of intervention) 
 
HADS – Anxiety  
(By 3-month follow-up) 
 
HADS – Depression 
(By end of intervention) 
 
HADS – Depression 




(By end of intervention) 
 
Work/Social functioning 













      
3.20 4.02 4.00 3.41   0.51 .62 





















  0.06 
 
  0.22 
 



















4.2.6 Differences in mental health and social functioning between those on medication 
and those not on medication 
Of the 60 completers, at the beginning of the intervention 28 patients were receiving 
psychotropic medication relevant to their mental health problem, while 26 did not have a 
prescription for psychotropic medication (the remaining six did not indicate either way). 
To examine whether any of the improvements in mental health or social functioning may 
have been attributed to the effect of medication, independent samples t-tests were 





medication across the various measures at post-intervention and 3-month follow-up. 
Table 4.8 displays that irrespective of the person’s psychotropic medication status, the 
degree of improvement across all outcomes at post-treatment and 3-month follow-up 
was not significantly different. 
 
Table 4.8 Differences in mental health and functioning improvement between those 
on medication and those not on medication  
Outcome measure 
 
On medication (n = 28) No medication (n = 26) 
 
 
t p M SD M SD 
 
HADS – Anxiety  
(By end of intervention) 
 
HADS – Anxiety  
(By 3-month follow-up) 
 
HADS – Depression 
(By end of intervention) 
 
HADS – Depression 






















      
3.64 3.82 3.63 3.54 0.01 .99 













































4.3 Summary of results 
Effectiveness of GSH for anxiety and depression  
 
Relative to a control period, GSH intervention led to significant improvement in mental 
health and social functioning outcomes by post-intervention, even under conservative 





health and social functioning were maintained at 3-month follow-up, and improvement 
in social functioning was maintained at 6-month follow-up. The vast majority of 
completers experienced clinically significant change at post-treatment, and these gains 
were generally maintained at follow-up, despite small numbers.  
 
Factors influencing mental health and social functioning outcomes 
 
Improvement in anxiety symptomatology was correlated with low self-efficacy in the 
first GSH session, high self-efficacy in the final session, and greater therapeutic alliance 
as rated by the patient in the first session. Improvement in anxiety symptomatology by 
the end of intervention was predicted by a regression model consisting of low self-
efficacy in the first session, and high self-efficacy in the final session.  
 Improvement in depressive symptomatology was correlated with low self-
efficacy in the first GSH session and greater therapeutic alliance as rated by the therapist 
in the final session. Improvement in depressive symptomatology by the end of 
intervention was predicted by a regression model consisting of therapist-rated 
therapeutic alliance in the final session and low patient self-efficacy in the first session.  
 
The role of therapeutic alliance in GSH 
 
Patient and therapist ratings of the therapeutic alliance were unrelated at the start of the 
intervention, though became significantly correlated by the end of intervention. 
Therapeutic alliance was rated significantly more positively by both patient and therapist 
at the end compared to the start of intervention. Therapeutic alliance was rated 
significantly more highly by completing patients than by their therapists. Discrepancies 
in therapeutic alliance ratings between patients and therapists were not related to 
improvements in mental health or social functioning. 
 
The wider impact of GSH on primary care services 
 
Patients saw their GPs for significantly fewer appointments regarding their mental health 





period preceding their intervention. Patients consulted with other professionals regarding 
their mental health slightly more following GSH, but not significantly so.  
 
Differences between GSH completers and non-completers 
The only baseline variable which distinguished completers from non-completers was 
socio-economic classification such that those participants from a higher socio-economic 
classification were significantly more likely to complete the GSH intervention than those 
participants from a lower socio-economic classification. 
 
Differences in mental health and social functioning improvements between GSH services  
With regard to improvements in anxiety, depression, and work and social functioning at 
the end of GSH intervention and at 3-month follow-up, there were no significant 
differences between two different GSH services, suggesting that both services were 
comparable in terms of their effectiveness.  
 
Differences in mental health and social functioning improvements between those on 
medication and those not on medication  
The prescription of psychotropic medication prior to GSH had no bearing on the degree 
of improvement in mental health across the GSH intervention compared to those who 
had not been prescribed psychotropic medication, indicating that GSH can be effective 



















This chapter will discuss the key findings relating to the study’s central hypotheses and 
secondary research questions, in the context of the literature critiqued within the 
systematic review of Chapter 1 and other relevant literature. The key findings will be 
considered in relation to the strengths and limitations of this study, before widening the 
discussion to reflect on the implications of the current findings for clinical practice and 
policy, and to suggest directions for future research. 
 
5.1 Effectiveness of GSH for anxiety and depression  
 
Hypothesis 1a: Patients with mild to moderate anxiety and/or depression will show 
significant improvements in mental health and social functioning at post-treatment 
relative to a control period. 
 
Patients’ mental health and social functioning outcomes were significantly improved by 
post-treatment upon completion of their GSH intervention. This finding was further 
corroborated by the large effect sizes demonstrating the improvement across the duration 
of the intervention. These large effect sizes are consistent with those found in a recent, 
large-scale cohort study evaluating low-intensity interventions such as GSH in two 
Improving Access to Psychological Therapies (IAPT) sites (Clark et al., 2009). The 
significant improvements observed within the completer sample were obtained even 
within conservative intent-to-treat (ITT) conditions, although the corresponding effect 
sizes under ITT were more moderate as would be expected. In comparison to the 
reviewed GSH studies within Chapter 1, the post-treatment effect sizes obtained here 
under ITT are generally midway between the large post-treatment effect sizes typical of 
non-clinical GSH studies (e.g. Andersson et al., 2005; Furmark et al., 2009) and the 
small effect sizes typical of clinical GSH studies (e.g. Mead et al., 2005; Salkovskis et 
al., 2006). Of the studies reviewed within Chapter 1, the post-treatment ES is 
comparable to the clinical-based study of Richards et al. (2003); d = 0.49, and the non-





found that nurse-guided CBT self-help was not any more effective than ordinary GP 
care, while the latter study found that internet-based CBT was effective in reducing 
depressive symptoms compared to waitlist control. Therefore, the current study 
demonstrates effectiveness of GSH to a greater extent than the previously reviewed 
clinical studies but to a lesser extent than the reviewed non-clinical studies (other than 
Warmerdam et al., 2008). 
 Some of the discrepancy between the current study and the clinically-
representative studies reviewed within Chapter 1 may be due to the non-randomised 
design and lack of a distinct control group within the present study. In light of this, the 
current findings were examined in the context of more comparable GSH studies (e.g. 
Farrand et al., 2008; Lucock et al., 2008; Lucock et al., 2011). The study of Farrand et 
al. found that GSH was effective in reducing HADS anxiety and depressive 
symptomatology from baseline (both p < 0.01), but the study was uncontrolled and did 
not report an effect size (ES). Compared to the current study, Lucock et al. (2008) found 
a smaller ES (d = 0.27) for improvement in anxiety symptoms, but their lower ES may 
be due to the guidance consisting of only 40 minutes, in contrast to a range of 90 to 160 
minutes of guidance in the current study. More recently, Lucock et al. (2011) conducted 
a pragmatic randomised controlled trial of GSH for anxiety and depression in a clinical 
setting and found a similar ES (d = 0.38) to the current study. Therefore, the current 
study adds to the evidence base by being one of only a few studies which has 
demonstrated GSH effectiveness within a clinical setting. Possible reasons for the higher 
effect sizes observed in the current study may include: milder baseline symptomatology; 
different self-help manuals being differentially effective; and the lack of a distinct 
control group.  
 By having a control period prior to introduction of the intervention, in which 
each participant served as their own control, the likelihood is increased that the mental 
health and functioning improvements are due to the GSH intervention. However, it 
should be noted that the improvement in anxiety symptoms across the duration of the 
control period approached significance (t = 1.77, p = .08). This suggests that further time 





given the potential for spontaneous remission of mild to moderate mental health 
symptoms (Posternak & Miller, 2001). While these findings encourage caution in 
interpreting the extent to which improvements in anxiety symptomatology were due to 
the intervention, it remains true that those who completed GSH had significantly 
improved symptomatology by the end of intervention compared to the control period 
and these changes were associated with large effect sizes. Differences in medication 
seem unlikely to explain this improvement as the degree of improvement across all 
outcome measures was not differentially influenced by medication status (i.e. those 
receiving versus those not receiving psychotropic medication at the start of 
intervention). Therefore, there seems to be some direct result of the person’s completion 
of the GSH intervention which facilitated mental health improvement. 
 Given the apparent effectiveness of GSH within a clinically-representative 
sample, it is worth considering what else may explain the current study’s moderate 
effect sizes under conservative ITT conditions. It may be that the patients in the current 
study began with a milder level of symptomatology than other studies and were thus 
better-placed to benefit from a low-intensity intervention such as GSH. Indeed, in 
contrast to the study of Mead et al. (2005) in which the baseline combined HADS mean 
score was 25.26 (SD = 6.66), the corresponding baseline mean score in the present study 
was 19.33 (SD = 6.06). Some previous GSH studies (e.g. Lovell et al., 2008; Mead et 
al., 2005) have included individuals with moderate to severe anxiety or depression 
which may not be suited to a low intensity intervention such as GSH. However, as Mead 
et al. (2006) argue in their response to an article (Young et al., 2006) which debated the 
initial findings of Mead et al. (2005), it is possible that patients with initial milder 
symptomatology would not demonstrate any additional benefit of intervention over-and-
above that which would be expected over time within a control group. With regard to 
this latter point, it is difficult to disentangle the argument further due to the lack of a 
distinct control group within the current study. Although a control period was achieved 
prior to intervention by participants serving as their own control, the lack of a parallel 
control group across the duration of the intervention makes it difficult to ascertain 





the transient nature of many of the problems targeted by low-intensity interventions is 
conducive to spontaneous improvement over time, irrespective of whether GSH 
intervention occurred. 
 
Hypothesis 1b: Improvements in mental health and social functioning observed at post-
treatment will not be maintained at 3- and 6-month follow-up. 
 
Due to the vast majority of small effect sizes at follow-up within the clinically-
representative studies reviewed within Chapter 1, it had been hypothesised that GSH 
effectiveness at post-treatment would not be maintained at follow-up. Contrary to this 
hypothesis, the improvements in anxiety, depression and work/social functioning 
observed across the intervention were also maintained at 3-month follow-up, again with 
large effect sizes within the completer analysis. At 6-month follow-up, improvements 
from post-treatment were no longer statistically significant for anxiety and depression 
outcomes, but improvement in work and social functioning remained statistically 
significant. Due to the mean improvement in anxiety and depressive symptoms at 6-
months being considerably greater than observed in the control period and having a 
comparable effect size to earlier time points, it is possible that the non-significance is an 
artefact of the small sample size available at this stage (n = 16) rather than a true 
reduction in effectiveness.  
 Nonetheless, although comparison with the reviewed studies of Chapter 1 was 
more limited by the lack of ITT analyses possible at follow-up, the indication of mental 
health and functioning improvements being maintained at 3-month follow-up within the 
completer sample is consistent with some of the findings from previous studies. Of the 
studies reviewed within Chapter 1, a large ES (d = 0.69) was obtained for internet-GSH 
at 1-month follow-up of anxiety symptom improvement (Warmerdam et al., 2008). 
However, this was a non-clinical based study and was followed up at a relatively early 
interval. More recently, a primary care based RCT which was specific to depression 
found significant benefit (d = 0.42) of GSH versus treatment as usual in reducing 





good quality RCTs in clinical practice can demonstrate effectiveness at longer-term 
follow-up – at least for depression. In terms of suggested clinical effectiveness at 3-
months, the discrepancy between the current findings and the clinical studies reviewed 
earlier could be due to a couple of reasons. For instance, the lack of a distinct control 
group in parallel with the intervention may have given an over-inflated sense of how 
effective the intervention was relative to control within the current study. Similarly, the 
fact that ITT analyses at follow-up were not possible for this study in contrast to the 
reviewed studies earlier could also explain the more conservative findings of the RCTs.  
 However, akin to the findings of Williams et al. (2008) it is possible that 
effectiveness at 3-months was a fair reflection of maintained improvement because GSH 
does continue to be effective at that stage. The possibility for this is perhaps heightened 
given the enduring nature of the intervention in which individuals are typically given 
more self-help workbooks to work through beyond the final session of the intervention. 
Therefore, with the premise being that the intervention is still ‘active’ by virtue of the 
person being their ‘own therapist’ in working through their self-help workbooks, it is 
possible that this ongoing learning and reflection led to continued effectiveness of GSH 
in the medium-term. In addition, the significant improvement in self-efficacy by 
intervention-end is perhaps indicative that individuals generally believed more in their 
own ability to enact change having progressed through and completed the intervention. 
As such, a sense of renewed self-efficacy may have helped maintain the mental health 
and functioning gains seen at 3-month follow-up. 
 Regarding the lack of significant improvement relative to control at 6-month 
follow-up, it is possible that any renewed self-efficacy and increased motivation 
following GSH could not be sustained in the longer-term. Alternatively, given that the 
mental health problems of those who access GSH are typically of a more transient nature 
than seen in conventional CBT, it is possible that previous psychosocial stressors re-
appear or new stresses begin to manifest within the passage of time. However, these 
interpretations conflict with evidence of sustained improvement in work and social 
functioning at 6-month follow-up. In addition, the maintained moderate effect sizes at 





depression would have remained statistically significant at 6-month follow-up. 
Therefore, it is perhaps more likely that a larger sample size at this point would have 
conveyed significantly greater improvement, particularly as GSH has been observed to 
be effective at longer-term follow-up in larger cohort studies (e.g. Clark et al., 2009). 
However, again this would need to be countered by the lack of ITT analysis, which 
could inflate the extent of maintained improvement. It is difficult to draw comparisons 
with the aforementioned clinically representative studies due to a range of differences 
specific to GSH (e.g. manual used, duration of intervention, person providing the 
intervention). The clinical study which used the same outcome measure (HADS) and 
was perhaps most similar to the current study was that of Mead et al. (2005). As argued 
previously, the baseline symptomatology of individuals in the RCT by Mead et al. 
appeared to have a severity significantly greater than that of the current study; this 
would clearly have implications for any difference in findings between the two studies at 
follow-up as well as post-treatment. 
   
5.2 The wider impact of GSH on primary care services 
 
Do patients have fewer contacts with services regarding their mental health and use a 
lower quantity of psychotropic medication in the three-month period following guided 
self-help intervention compared to the three-month period prior to intervention? 
 
Analysis revealed that patients consulted GPs regarding their mental health on 
significantly fewer occasions in the three-month period following GSH intervention 
compared to the three-month period preceding their intervention. Other mental health 
professionals were consulted on more occasions following GSH rather than prior to 
GSH, but not significantly so. In addition, psychotropic medication was prescribed less 
often in the corresponding period following GSH compared to prior to GSH. Together, 
these findings indicate that GSH intervention is effective in reducing patients’ 
consumption of primary care services. While detailed analysis of cost-effectiveness was 
beyond the scope of the current study, these findings are supportive of the beneficial role 





economically as well as clinically. The implications of these findings will be discussed 
later within this chapter. 
 
5.3 Differences in GSH effectiveness between services 
 
The current study explored the effectiveness of GSH in different services, though 
analysis revealed that the two main services were broadly equivalent in terms of 
effectiveness as evidenced by improvement in symptomatology of anxiety and 
depression, as well as work and social functioning, both at post-treatment and follow-up. 
The third service did not have a sufficient number of patients to warrant a comparison of 
all three services. This comparable effectiveness was found despite inherent differences 
between the two main services and gives greater confidence that the effectiveness is 
externally valid and generalisable rather than due to a spurious finding unique to the 
idiosyncrasies of one service. For instance: Service A was provided by one assistant 
psychologist at any one time, while Service B was provided by four guided self-help 
workers concurrently; Service A used a self-help manual specific for anxiety (Stuckey & 
Millar, 2003) or for depression (Williams, 2006) while Service B used a broader range 
of self-help materials; Service A had a significantly shorter mean GSH intervention 
duration than Service B. Similarly, Service A saw patients for intervention across 
significantly fewer sessions than in Service B. Clearly, such differences in number of 
appointments and duration of intervention have implications for the optimal GSH 
service model, as will be discussed later. The broadly similar effectiveness of GSH 
across these two distinct services, despite differences in service characteristics, perhaps 
points to the relative importance of factors specific to the intervention (e.g. self-help 
manuals used, CBT as the treatment modality) versus factors non-specific or common 
across psychological therapies (e.g. patient self-efficacy or therapeutic alliance) in 









5.4 Factors influencing GSH outcomes 
 
Hypotheses 2a, 2b and 2c: Patients who have greater self-efficacy, who are of higher 
socio-economic status and who experience a greater therapeutic alliance with their 
therapist, will benefit to a greater extent from GSH in terms of improvement in mental 
health and social functioning. 
 
Essentially, the above hypotheses were not supported by the evidence. Regression 
analyses revealed that greater improvement in anxiety symptoms was predicted by a 
model consisting of lower self-efficacy in the first GSH session and higher self-efficacy 
in the final session. Similarly, greater improvement in depressive symptoms was 
predicted by a model consisting of lower self-efficacy in the first session, in addition to 
greater therapeutic alliance as rated by the therapist in the final session. These findings 
will be discussed in more detail with regard to each individual predictor. 
 However, with regard to improvement in work and social functioning, it was 
surprising that none of the factors were predictive of this outcome. Although, the 
relationship between patient self-efficacy in the final session and improvement in work 
and social functioning approached significance, suggesting that there was a trend for 
patients’ sense of coping with everyday life (in terms of work, family life, home 
management, social activities and private leisure activities) to improve in parallel with 
their increased sense of coping. Aside from exploration of the three main factors, 
improvement in work and social functioning was significantly correlated with parallel 
improvement in anxiety and, particularly, improvement in depressive symptomatology. 
This is evidence of the wider impact that GSH can have in not only improving mental 





Patient self-efficacy was predictive of both anxiety and depressive improvement across 





efficacy were likely to benefit from GSH to a greater extent than those starting GSH 
with high self-efficacy. Furthermore, patients with greater self-efficacy in the final 
session experienced greater anxiety improvement.  
 The hypothesis had asserted that those with higher self-efficacy would benefit to 
a greater extent from GSH than those with lower self-efficacy. This had been based on 
previous evidence which had indicated that higher self-efficacy facilitated better self-
help outcomes (Mahalik & Kivlighan, 1988), and based on a large survey of mental 
health practitioners stating higher patient self-efficacy to be one of the most predictive 
factors of successful self-help outcomes (MacLeod et al., 2009). However, as was noted 
within Chapter 2, these studies relate almost exclusively to self-help rather than guided 
self-help. In contrast, an earlier guided self-help study found that higher patient self-
efficacy was associated with reduced improvement in anxiety symptoms (Hutchison, 
2007). It is possible that the latter finding was an indicator of a pattern specific to guided 
self-help as opposed to ‘pure’ or non-guided self-help, in which lower self-efficacy 
facilitates greater mental health improvement in guided interventions. A plausible 
mechanism for such a relationship could be that a patient who has low self-efficacy is 
more likely to have an external locus of control, thereby identifying with the therapist as 
being the main agent of change. Therefore, within a guided intervention such as GSH, 
the patient’s expectancy of the therapist to enact change could enhance their engagement 
with the guided nature of the intervention, thereby maximising their progress across the 
intervention. In contrast, a patient with higher self-efficacy might be expected to have an 
internal locus of control, thereby identifying oneself rather than the therapist as the main 
agent of change. Therefore, within a guided intervention such as GSH, the patient’s 
relatively minimised expectancy of the therapist to enact change could limit their 
engagement with the guided aspect of the intervention, thereby limiting their progress 
across the intervention.  
 Alternatively, it is possible that those with higher self-efficacy had milder initial 
symptomatology, thereby limiting the scope for greater improvement compared to those 
with low self-efficacy whose baseline symptomatology may have been more extensive. 





GSH session was categorised, albeit arbitrarily, to those with ‘low’ self-efficacy (scores 
≤ 26) or ‘high’ self-efficacy (scores > 26) there were significant differences in baseline 
symptoms of anxiety and depression for these two groups. This raises the possibility that 
milder baseline symptomatology led to less of a margin for improvement in symptoms 
across the duration of the intervention for those with high self-efficacy. However, 
because the outcome variable for the regression model was the improvement in 
symptomatology from the first to final GSH session, the relative baseline differences are 
accounted for to a certain degree by virtue of the outcome variable intrinsically 
comprising baseline scores.  
 The significant role of higher self-efficacy in the final GSH session being 
predictive of improvement in anxiety symptoms is suggestive of the notion that as 
patients progress through their intervention, they become increasingly confident in their 
own abilities to tackle their presenting problems. There are a couple of reasons why this 
may have emerged as a significant predictor of anxiety improvement as opposed to 
depression improvement. For instance, the wider range of anxiety versus depression 
symptomatology at baseline may have afforded greater opportunity for this factor to 
influence anxiety improvement. Alternatively, it may be that the CBT skills for tackling 
anxiety (e.g. graded hierarchies) are more straightforward for patients to proceed with 
sooner than the CBT techniques for tackling depression (e.g. thought challenging) and 
where motivation may be more limited to facilitate improvement in depressive 
symptoms.  
  
5.4.2 Therapeutic alliance 
Although no evidence exists indicating the role of therapeutic alliance in influencing 
GSH outcomes, it had been hypothesised that greater therapeutic alliance would have 
facilitated greater improvement in symptoms given that the establishment of a positive 
therapeutic alliance is regarded as one of the first steps of therapy (Beck et al., 1979). 
Finding that therapeutic alliance as rated by the therapist in the final GSH session was 
predictive of improvement in depressive symptoms was an interesting outcome. This 





impact within a short-frame such as within GSH interventions. However, it may be that 
therapists simply view their patients more favourably if they appear to respond well to 
the intervention. Due to a lack of evidence on this topic, it is unclear why therapeutic 
alliance as rated by the therapist emerged as a significant predictor and why it was 
predictive specifically of improvement in depressive (as opposed to anxiety) symptoms. 
It is possible that the therapists’ rating within the final session was the most accurate 
reflection of the therapeutic alliance, given the possibility that their ratings within the 
first session may have erred on the side of caution. Also, it is possible that the almost 
universal positive ratings of the therapeutic alliance by patients within the first and last 
sessions led to less distinction between therapeutic ratings, thus giving less scope for 
patients’ ratings to emerge as a predictive variable. In contrast, it could be speculated 
that therapists’ ratings within the final session offer a chance for accurate reflection on 
their level of engagement with their patient across the intervention and less conservatism 
than may have been the case in the first session. In addition, having understandably 
experienced therapeutic alliances significantly more often than patients, therapists may 
be provided with the opportunity to reflect on a greater variety of therapeutic alliances, 
enabling them to draw a balanced, informed judgement of the alliance relative to their 
wealth of previous experience. 
 Otherwise, it may be that therapeutic alliance as rated by the therapist was 
predictive only of depression improvement rather than anxiety improvement due to the 
benefits of a positive therapeutic alliance (e.g. empathy and a positive attachment; 
Bordin, 1979), directly countering symptoms more typical of depression (e.g. loneliness 
and social withdrawal). Also, with motivation typically being more symptomatic of 
depression than anxiety, it may be that improvement in depressive symptoms was more 
influenced by therapeutic alliance due to those patients’ greater need for the 
motivational support of a positive other (i.e. their therapist). Additionally, it is possible 
that therapeutic alliance did not emerge as a significant predictor of anxiety 
improvement due to the key role of self-efficacy in that regard, as evidenced by the large 
proportion of variance explained by self-efficacy. Nonetheless, together the above 





influencing GSH outcomes despite the brevity of the intervention. This evidence is 
consistent with a recent meta-analysis of comparative GSH and traditional 
psychotherapy studies in which the resultant equivalent effectiveness was interpreted as 
being indicative of the contact per se between therapist and patient being essential rather 
than the amount of contact (Cuijpers et al., 2010). 
 
Do patients’ views correspond with therapists’ views regarding the nature of their 
therapeutic alliance? 
Among the 60 people who completed the GSH intervention, there was not a significant 
correlation between patients’ and therapists’ ratings of the therapeutic alliance within the 
first appointment. However, finding that their views were significantly correlated within 
the final appointment conveys that some early disparity in therapist and patient views of 
the therapeutic alliance did not prevent greater concordance in their views by the end of 
GSH intervention. It is possible that some of the early disparity could be explained by 
therapists being more realistic or conservative, whereas patients may have been 
responding in a socially desirable manner to portray the alliance favourably. This 
possibility had been pre-empted by reassuring patients that their responses would only 
be accessible to the lead researcher, not their therapist, and by asking patients to 
complete their therapeutic alliance rating independently of the presence of their 
therapist. However, it is possible that this was not always feasible in practice, and even 
if it was, it is possible that this was not sufficient to enable patients to respond as openly 
as they may have liked. As there was no significant interaction between patients’ and 
therapists’ ratings over time, it is unlikely that one half of the alliance had altered their 
perspective significantly more than the other half of the alliance. Rather, it is possible 
that the significant correspondence of therapists’ and patients’ ratings in the final session 
was due to therapists being less conservative by the final session, while simultaneously, 
due to a positive alliance being generated during the intervention, patients may have 
rated the therapeutic alliance positively as a more genuine reflection of their perception 





 With regard to the lack of concordance between patients’ and therapists’ ratings 
in the first appointment, analyses revealed that this disparity was not significantly related 
to improvements in mental health or social functioning, or to distinguishing completers 
from non-completers. Therefore, any discordance early within the GSH intervention did 
not appear to adversely affect the extent to which someone subsequently benefited from 
GSH. It is likely that because both patients and therapists overwhelmingly rated the 
alliance positively (albeit differently) at this early stage, that any effect of disparity upon 
outcomes would have been minimised. Also apparent from analysis of the therapeutic 
alliance was that patients rated the therapeutic alliance significantly more highly than 
therapists for the duration of the intervention, suggesting that for the people who 
completed the intervention, they appreciated and responded well to the therapist 
providing their guidance. Finding that both halves of the therapeutic relationship rated 
the alliance significantly more highly in the final session compared to the first session is 
suggestive of both the patient and therapist identifying the intervention to have been 
suitable for patients needs for those who complete the intervention. 
 
5.4.3 Socio-economic status 
The general absence of socio-economic status within significant correlations and 
regression models may underline its lack of influence in determining GSH effectiveness. 
Therefore, despite lower SES being associated with poorer mental health outcomes 
(Scottish Executive, 2005), it did not seem to make a difference either way in terms of 
people benefiting from the intervention. This concurs with the study of Keeley et al. 
(2002) in which practitioners who were surveyed believed that SES would not be 
influential in determining self-help outcomes, but is in contrast to a more recent study in 
which practitioners generally believed that SES would be an important factor in 
determining effectiveness (MacLeod et al., 2009). However, the lack of influence of 
SES may have been a reflection of the sample being relatively homogeneous. Of the 60 
completers, 65 per cent were categorised within the highest social class, with a further 
13 per cent in the second-highest of the five social classes. Therefore, its lack of 





likelihood of predicting outcomes. However, although SES did not impact directly upon 
effectiveness, SES did have a role in distinguishing completers from non-completers - as 
will be discussed next - suggesting that this is an important factor to be considered 
perhaps earlier at the referral and pre-intervention stage, rather than once the 
intervention is underway.  
 
5.5 Differences between GSH completers and non-completers 
When comparing the scores of 60 completers versus 37 non-completers on baseline 
variables including: age; socio-economic status; anxiety symptomatology; depressive 
symptomatology; work and social functioning level; self-efficacy; and therapeutic 
alliance as rated by both the patient and therapist within the first GSH session, the only 
variable which significantly distinguished those who defaulted from those who 
completed the GSH intervention was socio-economic status (SES). Specifically, 
completers had a significantly higher SES classification than non-completers. This 
suggests that socio-economic status is influential in affecting individuals’ engagement 
with GSH, which has implications for the workability of GSH across a broad 
demographic range, given the remit of low-intensity interventions such as GSH to 
increase the population’s access to psychological therapies (DoH, 2005). The links 
between lower SES and poorer mental health outcomes are well-evidenced (Scottish 
Executive, 2005) and as the NS-SEC classification system captures “basic structuring 
principles of society such as income and housing” (Chandola & Jenkinson, 2000), the 
current study highlights that there is something about the GSH services analysed which 
limits the amount of engagement and benefit possible for less affluent areas of society. If 
GSH is to maximise its accessibility then it needs to be an intervention within a service 
which can flexibly accommodate the varying needs of different demographic strands of 
the population accessing such interventions.  
 Within the present study, the reasons are unclear as to why people of lower SES 
defaulted significantly more than people of higher SES and this is worthy of further 
investigation. However, a similar GSH cohort study has found a significant association 





terms of GSH attendance (Farrand et al., 2008). In the current study, of the 37 people 
who defaulted, 20 did so prior to the first session, while the remaining 17 did so after 
attending their first session. It is possible that the same mechanism underpins this 
differential defaulting – for example, it could be that psychosocial stressors were simply 
too varied and multitudinous for people to sustain their engagement with such a low-
intensity, specific intervention. Alternatively, for those non-completers who initially 
engaged with GSH services, their subsequent drop-out from treatment may be further 
indication of adults of lower SES having lower perceived confidence, knowledge and 
skills to enact changes necessary for resilience during sustained stress (e.g. Hibbard et 
al., 2004). As such, it is possible that adults of lower SES within the current study were 
sufficiently influenced by a negative self-concept regarding their ability to change, that 
defaulting seemed like the best option available to them. Alternatively, it may be that 
there was something specific to the GSH services which limited the engagement of 
individuals of lower SES to GSH – for instance, previous work has highlighted the 
influence of the readability of self-help manuals on patients’ engagement with self-help 
(Martinez et al., 2008). It may be that the self-help manuals which were used in the 
present study were less accessible to those who defaulted due to their readability. 
Clearly, future studies could illuminate the mechanisms behind lower SES defaulting, 
perhaps with qualitative investigation which follows-up patients after they have 
defaulted treatment, although this could be inherently impractical.  
 
5.6 Methodological strengths 
 
As was documented within the preceding systematic review, this study was motivated by 
a lack of clinically-representative studies within the evidence-base for CBT-based GSH 
for anxiety and depressive disorders. The current study adds valuable evidence to the 
literature by virtue of sampling a relatively large number of participants within primary 
care and across three different settings which routinely offer GSH as a low-intensity 
intervention. With an evidenced tendency for GSH research to be indicative of efficacy 
and often lacking external validity, the current research offers generalisable, practice-





harmonious with an impetus within psychotherapy research more generally for an 
increased drive to obtain evidence from routine clinical practice to add to the findings 
from efficacy RCT studies (Cahill et al., 2010; Shadish et al., 2000). Therefore, having 
sampled from a clinically-representative population within established primary care 
settings, the indication of clinical effectiveness within the current research (and under 
conservative intent-to-treat conditions) offers validating evidence that guided self-help is 
effective in clinical practice, not just in efficacy studies. While similar effectiveness has 
been indicated in recent clinically-representative GSH RCT studies (e.g. Lucock et al., 
2011; Williams et al., 2008), the former study lacked follow-up evaluations, while the 
latter was specific to depression. In contrast, the current study adds to the evidence base 
by investigating depression and anxiety, and by following up effectiveness outcomes 
beyond post-treatment. However, a caveat should be noted: the lack of a control group in 
parallel with the intervention may have led to an overestimation of effectiveness within 
the current study. 
 By utilising 3-month and 6-month follow-up, the present study attempted to fill a 
gap within the GSH evidence-base in which there tends to be an over-emphasis on post-
treatment findings (e.g. NICE, 2009) rather than whether effective outcomes are 
maintained in the medium to longer-term. Although the high rate of attrition saw 
relatively small numbers of people completing outcome measures at follow-up, the 
emerging evidence at 3-month, and to a lesser extent 6-month, follow-up was suggestive 
of mental health improvement and social functioning gains being maintained in the 
medium-term. Given the often less-entrenched nature of mental health problems 
typically targeted by GSH interventions, without a follow-up evaluation it would be 
impossible to tell firstly, whether gains were maintained at all, and secondly to what 
extent people’s gains at post-treatment are maintained due to the intervention or simply 
to the passage of time. Maintenance of gains at follow-up suggests that individuals 
continue to benefit having learned something specific from GSH rather than simply 
feeling better by having someone listen to their problems without necessarily learning 
anything new. In having a control period, albeit shorter than the duration of intervention, 





rather than the passage of time. However, the GSH evidence-base for effectiveness at 
follow-up would be bolstered further by evaluating GSH in parallel with a distinct 
control group.  
 Earlier discussion within Chapter 1 highlighted the increasing demand in GSH 
research for a focus upon the factors which may be predictors of treatment effect within 
studies due to a lack of understanding regarding who benefits from GSH (e.g. Lovell et 
al., 2008). The present study addressed this void in two ways: firstly, by exclusively 
focusing the research upon clearly-defined guided self-help interventions, not self-help 
in more general terms; and secondly, by investigating the impact of a variety of non-
specific factors upon GSH outcomes. In examining the respective roles of patient self-
efficacy, socio-economic status and therapeutic alliance within GSH, an attempt was 
made to explore factors beyond the specific aspects intrinsic to GSH interventions. Such 
an approach is consistent with observations within the evidence base that the role of 
non-specific, common factors is yet to be adequately addressed within self-help 
generally (Peck, 2010). Furthermore, the quantitative analysis of the role of therapeutic 
alliance in GSH appears to be a feature unique to the current study. Such a focus is 
worthwhile to help disentangle how important the ‘guided’ element of GSH actually is, 
and what the mechanisms behind this guidance actually are in order for it to contribute 
to effectiveness. Measuring therapeutic alliance from the perspective of both the patient 
and therapist provides additional corroboration of the alliance and increases confidence 
in the true extent of the therapeutic alliance.   
 On the theme of corroboration, the current study attempted to bolster its findings 
by measuring not only mental health symptomatology, but also work and social 
functioning, given the debilitating effect mental health problems can have in limiting the 
everyday aspects of people’s lives. Similarly, by assessing the clinical effectiveness of 
GSH not only directly, but also indirectly in terms of the wider impact of GSH upon 
service consumption, an attempt was made to gauge the beneficial effect (or otherwise) 
of GSH within the stepped-care approach and clinical setting more broadly to enhance 
the external validity of the study. Finding that GSH was effective not only for 





subsequent consumption of GP services, underlines the wider impact that a low-intensity 
intervention like GSH can have in terms of cost-effectiveness for services. In addition, 
finding that simultaneously having a psychotropic prescription did not differentially 
influence GSH effectiveness outcomes, highlights the importance of GPs having the 
pathway to refer individuals to an intervention like GSH – it is cost effective for GPs as 
an alternative to prescribing medication and by having fewer appointments with patients 
after their GSH attendance it increases their own service capacity. It is also likely that 
when GSH is effective it prevents a person’s mental health problems from becoming 
more entrenched, thus facilitating further cost-effectiveness by reducing the likelihood 
that that individual will subsequently need to access higher, more specialist services 
within the tiered system. 
 
5.7 Methodological limitations 
 
The absence of a distinct control group within this study necessarily tempers the 
conclusions which can be drawn regarding the clinical effectiveness of GSH. Given the 
need for statistical power, the limited size of the population accessing GSH services 
within the time-frame was prohibitive of resourcing a comparable control group from 
that same population. In addition, the ethical ramifications of denying individuals within 
a control group an intervention for up to 6 months, limited the opportunity to have a 
control group in parallel with the intervention. However, to provide some indication of 
control, a design was adopted which enabled each participant to act as their own control 
participant, by virtue of designing a control period prior to the participant’s intervention 
period. While the design was conceptualised for this control period to be comparable in 
duration to the duration of the GSH intervention (i.e. both approximately four weeks), 
the practicalities of conducting research within existent GSH services within clinical 
practice, as well as the ethical considerations described above, led to the mean duration 
of control and intervention periods being markedly different, particularly with respect to 
Services B and C, which typically operated a longer intervention duration than Service 
A. Despite efforts to encourage GSH services to adhere as closely as possible to the 





of reasons, including: patients cancelling or not attending their GSH appointments; staff 
illness; a perceived pressure on GSH workers to see patients sooner rather than keeping 
them waiting; and the ‘freezing’ of a GSH staff vacancy once a GSH worker had left 
their post. Nonetheless, since participants acted as their own controls, the risk of 
confounding factors (other than the passage of time) was perhaps minimised. 
Furthermore, in demonstrating that those completers who were prescribed psychotropic 
medication did not benefit to any greater extent from the GSH intervention than those 
completers who did not have a psychotropic prescription, the possible confounding role 
of medication in determining effectiveness was minimised. Yet, the MHU questionnaire 
which participants completed within their first GSH session to indicate their medication 
usage merely provided a snapshot; it was not possible to ascertain the amount of time 
that had elapsed since an individual may have started taking medication, nor to control 
for a potential confounding factor in that that individual may have started taking 
medication after the first GSH session but while their intervention was still ongoing.  
 While adequate power was achieved for t-tests and correlation analyses, the 
lower than required sample size of 76 for regression to achieve the standard accepted 
power value of .80 (Cohen, 1992) necessitated a post-hoc power calculation. The 
regression models for anxiety improvement and depression improvement achieved 
power of .66 and .70 respectively. The aforementioned gap in GSH service due to a 
vacancy freeze meant that a GSH service was inactive for around seven months, limiting 
the recruitment opportunities which had been envisaged. It is unclear whether a sample 
size of 76 would have differentially affected the roles of therapeutic alliance, self-
efficacy, and socio-economic status in influencing GSH outcomes than was otherwise 
indicated within the current sample.  
 These types of limitations are in some ways inherent in clinically-representative 
research, where there will be potential limitations due to issues such as imbalanced 
service demand and capacity, heterogeneity of GSH service provision across services, 
and participant attrition due to comorbid issues or unexplained issues. The high drop-out 
rate of 38 per cent was comparable to similar clinically-based GSH studies (43 per cent, 





lower socio-economic status in influencing those who dropped-out of the GSH 
intervention versus those who completed it highlights the potential for such non-specific 
factors to adversely affect engagement with GSH interventions. However, the 
subsequent homogeneity of higher SES within the completer sample has implications for 
the representativeness of the study, given that the bias towards completers being of 
higher social classes, limits conclusions regarding the effectiveness for individuals of 
lower socio-economic status. 
 
5.8 Implications for clinical practice and policy  
 
In the context of the wider literature, the present study adds to a limited evidence base 
for the effectiveness of GSH for anxiety and depression within clinically-representative 
populations and lends support to the inclusion of GSH within the stepped-care service 
model. The current study adopted a pragmatic recruitment method to maximise its 
external validity. Therefore, finding that GSH was equally effective across different 
services – despite differences in manuals, therapists, and intervention duration – 
suggests that the general concept of a person being guided by a therapist via a CBT-
based manual is one that can be effective within routine clinical practice. For the two 
services which had sufficient numbers to allow comparative analysis, the differences in 
intervention duration and number of GSH sessions were significant. As these services 
were equally as effective both at post-treatment and at follow-up, this suggests that GSH 
may be best delivered over a shorter time-frame (i.e. 4 to 5 weeks rather than 11 weeks) 
and a three-session intervention (rather than 4 sessions typical of Service B). In support 
of this, effectiveness of GSH for anxiety and depression has recently been demonstrated 
in a ‘2 + 1’ GSH model, consisting of three sessions with a total duration of 150 minutes 
(Lucock et al., 2011). Such an equivalent duration and session frequency led to 
effectiveness within Service A. This suggests that adopting these parameters more 
widely within the GSH service model would, importantly: a) ensure that patients receive 





patients to occur efficiently; and c) free up more service capacity to help meet the ever-
increasing demand for psychological therapies. 
 The preceding points have implications for services and policy in terms of the 
cost-effectiveness of aspects of the stepped-care model. For instance, if GSH can be 
delivered just as effectively across fewer appointments and within a shorter time-frame, 
this is likely to lead to economic efficiency, as discussed in previous literature (e.g. 
Bower & Gilbody, 2005). In addition, two findings within the current study add weight 
to the evidence outlining the wider economic impact of interventions such as GSH. 
Firstly, demonstrating that patients consult their GPs significantly less frequently and 
require less psychotropic medication following GSH compared to an equivalent time-
period prior to accessing GSH, underlines the wider positive impact of minimal 
interventions such as GSH upon cost-effectiveness. Secondly, current evidence of 
significant improvement in work and social functioning following GSH – gains which 
were maintained at 6-month follow-up despite a small sample size – reinforces the 
economic benefits of increasing access to psychological therapies as proposed in key 
literature (e.g. Layard et al., 2007). Within such articles, the argument for increasing 
access to psychological therapies was underpinned by the message that such investment 
in treating anxiety and depressive disorders would pay for itself due to a subsequent 
reduction in related costs (fewer appointments, fewer prescriptions, and fewer welfare 
benefits) and increased revenues via people returning to work. The current findings are 
consistent with such themes, albeit the longer-term enduring benefit – both economic 
and clinical – of GSH remains less clear and warrants further investigation. 
 Clinical effectiveness was demonstrated across GSH services in the present study 
despite a variety of therapists with varying professional experience and qualifications; 
this is consistent with previous research that found no difference between professionals 
and paraprofessionals in effecting GSH outcomes for anxiety and depression (Boer et 
al., 2005). Given the increasing skill-mix working within psychological therapies 
services, consideration should be directed to the optimal staff-group to deliver such 
interventions, as well as the optimal staff-group to train and supervise the professionals 





stepped-care model remains flexible and accessible for patients, should allow precious 
clinical resources to be maximised to meet demand and likely lead to further efficiency 
with regard to cost-effectiveness. 
 Within the systematic review of Chapter 1, it was suggested that there remains an 
unrealistic perception of the amount of benefit which people can gain from GSH (Lovell 
et al., 2008). In addition, numerous authors have asserted the need for more 
effectiveness research of GSH within routine clinical practice (e.g. Lucock et al., 2008) 
and the systematic review highlighted the need for effectiveness outcomes to be 
considered in the context of study quality, recruitment setting and timing of outcome 
measurement. The emphasis within the current study on recruiting within a clinical 
population and following up GSH outcomes after post-treatment, add value in 
demonstrating clinical effectiveness of GSH which is maintained after intervention for 
patients accessing primary care services. Nonetheless, the aforementioned limitations 
likely have an influence on the overall quality of the current study and reinforce the need 
for more pragmatic RCTs of GSH within clinical practice (e.g. Lucock et al., 2011; 
Williams et al., 2008). Pragmatic RCTs of GSH, in maximising external validity while 
achieving good internal validity, are necessary to balance the existent GSH evidence 
base. It is hoped this would increase the likelihood that future clinical recommendations 
(e.g. NICE) for depression and anxiety are based on a sound, externally valid evidence 
base which is reflective of the heterogeneity and complexities of everyday clinical 
practice.  
 However, the evidenced effectiveness within the current study clearly does not 
apply to everyone who is referred to GSH. Indeed, although socio-economic status 
(SES) did not influence GSH improvements directly, it did have an indirect impact in 
that those who defaulted the GSH intervention were of significantly lower SES than 
those who completed GSH. While this is a trend apparent in other psychotherapy 
research (e.g. Lewis et al., 2003), this perhaps needs further attention given that low 
intensity interventions such as GSH are designed to maximise the public’s options and 
access to psychological therapies. If there is a certain demographic strand (such as 





implications for ensuring that its future delivery is equitable and accessible. As GSH 
therapists typically see patients at their local health centre, this perhaps lessens the 
likelihood that travel time or cost are prohibitive factors leading to patients of lower SES 
defaulting. Rather, given the perhaps greater potential for patients of lower SES to have 
concurrent financial, housing or health issues, it is possible that their engagement with 
other support services limits their ability to engage with yet another service, such as 
GSH. Alternatively, it may be that this format of GSH, using written manuals, is one that 
is not conducive to engagement with this population, given the association between 
lower SES and educational level, and the influence of educational level on people’s 
engagement with self-help materials (e.g. Martinez et al., 2008). It is clear that there is 
currently a lack of understanding about what influences people of lower SES to default 
from GSH interventions. While future research could qualitatively attempt to follow-up 
those who default GSH, an onus remains on primary care services to develop equitable 
psychosocial interventions which are flexible to accommodate a variety of needs; 
emphasising the importance of engagement and maximising accessibility of stepped-care 
interventions such as GSH to deprived populations (e.g. STEPS; White, 2008).  
 
5.9 Avenues for future research 
 
In considering GSH clinical effectiveness and cost-effectiveness, it would be fruitful to 
discover whether future GSH studies replicate the current study in finding interventions 
of shorter duration consisting of three sessions to be just as effective as longer GSH 
interventions. Or indeed, whether both are effective but longer GSH interventions lead 
to larger effect sizes (e.g. Richards & Suckling, 2009) and greater clinically significant 
change in the longer-term.  
 While recent research has highlighted that expectancy of success is regarded by 
mental health practitioners as a factor likely to be important in facilitating self-help 
effectiveness (MacLeod et al., 2009), the importance of the individual’s expectancy of 
what GSH actually involves is less clear. For instance, as a large proportion of GSH 
referrals are likely to be decided at multidisciplinary triage meetings, it is possible that 





GSH service. If this is the case, there is the possibility that such individuals are not able 
to make a fully informed choice as to their treatment pathway, which may increase the 
likelihood that that individual defaults from GSH. Qualitative research could examine 
patients’ experience of this referral process to determine whether sufficient information 
is provided – whether by their GP initially or in a letter following triage – to enable the 
individual to have a realistic expectancy of what GSH involves and make a more 
informed decision earlier in the referral process regarding their engagement with GSH.  
 There still remains a need to better understand the relative influences of specific 
versus non-specific factors with regard specifically to GSH. Although there has been 
qualitative research in which practitioners have been asked about what factors influence 
self-help effectiveness (MacLeod et al., 2009), corresponding research from patients’ 
perspective is lacking. Retrospective qualitative studies could focus on asking patients to 
reflect on what they recognised as being the main mechanisms of change across their 
experience of GSH intervention. Additionally, given that therapeutic alliance was 
suggested to be a mechanism of change within the current study, it would be useful to 
have a more refined analysis of therapeutic alliance to illuminate whether certain aspects 
of this (e.g. developing a secure base, empathy, rupture repair) are more important than 
others in influencing GSH outcomes. 
 While the current study endeavoured to explore the contribution of a range of 
factors non-specific to GSH, the potential range of factors which could have been 
explored was much wider. For example, a survey of CBT practitioners identified that the 
majority regarded patients’ motivation and educational level as factors likely to facilitate 
self-help effectiveness (MacLeod et al., 2009). Ideally, future patient-based research 
will add to the patient-based evidence from the current study, in determining the relative 
influences of variables such as motivation and educational level versus, for example, 
patient self-efficacy and therapeutic alliance. As self-help materials become increasingly 
developed with regard to ensuring maximum readability or diversified to different media 
(Martinez et al., 2008) and greater adaptation occurs within self-help manuals of 
common factors such as therapeutic alliance and empathy (Richardson et al., 2010), the 





both self-help and specifically guided self-help - will necessarily increase our insight 




This study has provided evidence suggesting GSH is clinically effective in improving 
patients’ symptoms of anxiety and depression, as well as effective in improving their 
work and social functioning. Evidence has also indicated that improvements – both in 
mental health symptomatology and everyday functioning – can be maintained at least up 
to 3-month follow-up. Crucially, this effectiveness has been evidenced in routine clinical 
practice, has been shown to apply in different GSH services despite inherent differences 
therein, and has had a positive effect on reducing GP consultations and prescription of 
medication. Thus, the current study provides validating practice-based evidence of GSH 
working in clinical settings. Also, effectiveness outcomes have been shown to be 
influenced in different ways by self-efficacy, therapeutic alliance and socio-economic 
status. However, there remains a need to better understand the longer-term clinical and 
economic effectiveness of GSH and a need to further understand for whom GSH is 
effective in order to inform future evidence-based practice constructively.  
 
  
















The clinical effectiveness of CBT-based guided self-help for anxiety and depression:  
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Objectives. To determine the clinical effectiveness of guided self-help (GSH) for 
anxiety and depression in routine clinical practice, as well as the role of self-efficacy, 
therapeutic alliance and socio-economic status in influencing that effectiveness. 
Design. A within-subjects design was used in which participants served as their 
own controls by completing measures across a control period prior to GSH intervention.  
Methods. Participants accessing GSH services in routine clinical practice 
completed mental health (HADS) and work/social functioning (WSAS) outcome 
measures during a baseline period and then again at post-intervention and at three- and 
six-month follow-up. Self-efficacy, therapeutic alliance and socio-economic status were 
explored as possible predictors of effectiveness.  
Results. Sixty people completed GSH, with ITT analyses indicating significant 
moderate improvements in anxiety, depression and functioning at post-intervention. 
Gains appeared to be maintained at three-month follow-up, though by six-month follow-
up these were generally non-significant. Self-efficacy and therapeutic alliance emerged 
as significant predictors of improvement in mental health.  
Conclusions. Evidence from this study suggests that GSH can be effective in clinical 
practice, but maintenance of improved outcomes at longer-term follow-up remains 
unclear. Factors non-specific to the intervention such as self-efficacy and therapeutic 
alliance influence the amount of improvement which patients experience within GSH.  
Word Count: 200 
                                                 
†
 As Chapter 6 will be submitted to the British Journal of Clinical Psychology, it is formatted 
according to the author guidelines for that journal (see Appendix 13) 






There has been an impetus in the UK to improve patients’ access to psychological 
therapies (Department of Health, 2005; Scottish Executive, 2006). This has been 
targeted through a stepped care model in which the intensity of intervention is matched 
to the severity of mental health symptoms. Reflecting this stepped care approach, 
National Institute for Clinical Excellence (NICE) guidelines recommend the provision of 
cognitive-behavioural therapy (CBT) based guided self-help (GSH) intervention for 
anxiety and depressive disorders (NICE, 2007, 2009). However, much of the relevant 
GSH evidence cited by NICE (2009) is based on self-selected rather than clinical 
samples and on studies which have not evaluated outcomes beyond immediate post-
treatment.  
 
Effectiveness of GSH for anxiety and depression 
A comprehensive review of both self-help and guided self-help interventions for 
depression indicated greater effectiveness for guided interventions (Gellatly et al., 2007). 
The majority of studies reviewed by Gellatly et al. were based on self-selected, non-
clinical samples with symptoms of depression and the review did not state which studies 
were guided versus non-guided. Other reviews or meta-analyses have not distinguished 
guided self-help from self-help more generally (e.g., den Boer, Wiersma, & van den 
Bosch, 2004). As such, our understanding of the evidence for GSH effectiveness for 
anxiety and depression within clinical settings remains unclear.  
 A recent systematic review and meta-analysis of CBT-based GSH interventions 
found that studies which reported GSH effectiveness were less likely to have included 




follow-up mental health outcomes beyond post-treatment and were more likely to be 
based within self-selected or non-clinical settings rather than clinical settings (Coull & 
Morris, 2011). In contrast, studies which did not demonstrate GSH effectiveness tended 
to be based within routine clinical practice and reported data at longer-term follow-up. 
Furthermore, those reviewed studies reporting minimal (or no) effectiveness of GSH 
tended to be of a higher methodological quality. A primary objective of the current study 
was to determine the clinical effectiveness of guided self-help for anxiety and depression 
in routine clinical practice. 
 
Factors influencing GSH outcomes 
Numerous studies have highlighted the need to better understand the factors which may 
help explain peoples’ success (or lack thereof) within low-intensity interventions such as 
GSH (e.g., Coull & Morris, 2011; Lovell et al., 2008; MacLeod, Martinez & Williams, 
2009). It has been argued that much of the effectiveness seen within guided self-help 
may be due to non-specific factors (e.g. patient self-efficacy) rather than the self-help 
materials themselves (MacLeod et al.). The current study sought to determine whether 
factors such as self-efficacy, therapeutic alliance, and socio-economic status influence 
GSH outcomes.  
 No quantitative literature currently exists on the impact of therapeutic alliance on 
GSH outcomes for patients with depression and/or anxiety. However, establishing a 
positive therapeutic alliance has long been regarded as one of the first steps of therapy 
(Beck, Rush, Shaw, & Emery, 1979) and it seems reasonable to assume that patients’ 
and therapists’ experience of the therapeutic relationship could influence GSH 




outcomes, despite only meeting for three or four sessions. Consequently, a primary 
objective of the current study was to examine the impact of therapeutic alliance upon 
GSH outcomes. Indeed, a qualitative synthesis of GSH studies suggested that the 
therapeutic relationship is fundamental in determining to what extent people engage with 
self-help materials (Khan, Bower, & Rogers, 2007).   
 Patient self-efficacy has been evidenced to influence self-help effectiveness 
outcomes (Mahalik & Kivlighan, 1988). Perhaps this is not surprising given that self-
efficacy relates to a person’s belief in their ability to enact desired change through their 
own actions; a consideration relevant to GSH where the patient is required to take 
ownership of their therapeutic journey from the outset. More recently, a survey of 
mental health practitioners highlighted patient self-efficacy as one of the variables they 
deemed most predictive of successful self-help outcomes (MacLeod et al., 2009). 
However, very little published research examines the impact of patient self-efficacy 
upon mental health outcomes following guided self-help. Hutchison (2007) evaluated 
GSH effectiveness and found that self-efficacy was not predictive of mental health 
improvement, which was contrary to expectation. As such, it remains unclear to what 
extent patient self-efficacy affects patient outcomes, with regard to guided self-help 
where arguably the person does not need to be self-reliant to the same extent as is 
necessary for pure self-help. 
 There appears to be ambiguity amongst therapists regarding the degree to which 
socio-economic status is influential in determining self-help outcomes (Keeley, 
Williams, & Shapiro, 2002; MacLeod et al., 2009). Patients of lower socio-economic 
status negatively rate their confidence, skills and knowledge in enacting change 




(Hibbard, Stockard, Mahoney, & Tusler, 2004), which are likely to be important 
mechanisms of change within guided self-help. The current study investigated 
therapeutic alliance, patient self-efficacy and socio-economic status to determine 






To maximise the external validity of the study, any adult (aged 18 upwards) whose 
referral met inclusion criteria for locally-based NHS GSH services was eligible to 
participate in the research. Appropriate referrals to the service comprised low mood and 
mild to moderate anxiety and/or depression. Those scoring over 15 on the anxiety or 
depression scale of the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) were typically excluded from GSH interventions and referred to a higher 




In an attempt to achieve a control comparison while avoiding the ethical dilemma of 
denying patients an intervention for an extended period, each research participant acted 
as their own control by completing measures on two occasions separated by one month 
immediately prior to receiving the GSH intervention. Thus, each participant completed 
outcome measures approximately one month prior to beginning their GSH intervention, 
reflecting the typical length of wait between referral and intervention. Administration of 
these measures was repeated at the beginning of the first GSH session and again, 




approximately one month later, at the end of the last session of the intervention. This 
design was adopted to provide control (i.e., T2 - T1) versus intervention (i.e., T3 - T2) 
periods which were comparable in order to control for any change in symptoms which 
may have happened spontaneously irrespective of GSH intervention.  
 
Setting and intervention 
 
The research was conducted in three GSH services (A, B and C) within primary care 
settings across Lothian. Referrals to these services were received from GPs either 
directly or via multi-disciplinary triage meetings. Each service provides GSH 
intervention across three or four sessions (each typically lasting 30-45 minutes and 
typically across four to eight weeks) in which the patient is guided by an assistant 
psychologist or guided self-help worker, who in turn is trained and regularly supervised 
by a practitioner psychologist in the delivery of CBT-based GSH. The GSH therapist 
provided guidance in the use of written CBT-based workbooks which specifically target 




The two main outcome measures were the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983) and the Work and Social Adjustment Scale (WSAS; 
Mundt, Marks, Shear, & Greist, 2002). Both measures are well-validated and the HADS 
is routinely used within many primary care services, including those involved in the 
current study. The WSAS is recommended for use within an ‘Outcomes Toolkit’ for 
primary care outcome research (DoH, 2008). The HADS consists of 14 self-report items: 
7 anxiety and 7 depression items, each rated on a four-point Likert scale, with scores of 




11 and above on each subscale being indicative of clinically significant 
symptomatology. The WSAS consists of five items relating to the domains of: work; 
home management; social leisure activities; private leisure activities; and family and 
relationships, with high overall scale scores indicating greater functional impairment. 
 The measures used to gauge therapeutic alliance, self-efficacy and socio-
economic status were: the Working Alliance Inventory (WAI-s; Tracey & Kokotovic, 
1989); the Generalised Self-Efficacy Scale (GSES; Schwarzer & Jerusalem, 1995); and 
a self-coded version of the occupation-derived National Statistics Socio-economic 
Classification (NS-SEC) system (ONS, 2005). The 12-item WAI-s derives from the 36-
item original version (WAI; Horvath & Greenberg, 1989) and is a self-report 
questionnaire, with patient and therapist versions. It comprises three subscales which 
encompass the level of agreement and engagement between the patient and therapist on 
three aspects of therapeutic alliance: the treatment goals; how to achieve the treatment 
goals; and the extent of acceptance, trust and confidence between the patient and 
therapist. Respondents are asked to rate each question on a seven-point Likert scale, with 
higher composite scores indicating stronger therapeutic alliance.  
 The 10-item Generalised Self-Efficacy Scale measures perceived ability to 
respond to difficult and emotional situations primarily by seeing the self as the agent of 
change. Participants respond to the GSES across 10 items within a range of four 
responses from: (1) not at all true to (4) exactly true, culminating in an overall score, 
with higher scores indicating greater perceived self-efficacy. 
 The occupation-derived National Statistics Socio-economic Classification (NS-
SEC) system assigns people to social classes based upon their occupational title and 




level of responsibility within their employment. It has been evidenced to have both 
criterion and construct validity, and is recommended for use as a standardised tool 
within research (Rose, Pevalin, & O’Reilly, 2005). The four-item self-coded version of 
NS-SEC sub-classifies a person’s status into one of five categories: managerial and 
professional occupations; intermediate occupations; small employers and own account 





All patients who met the inclusion criteria for the GSH service were sent a research opt-
in pack consisting of baseline questionnaires comprising the HADS, WSAS, GSES and 
NS-SEC. The date individuals completed the questionnaires (indicated on their returned 
consent form) signalled the start of the control period. Where possible, a one month 
control period was sought before the first session of their GSH intervention in which the 
GSH therapist administered the HADS, WSAS and GSES at the beginning of the 
session. At the end of the first session, both the research participant and therapist 
completed their respective versions of the Working Alliance Inventory. The same 
measures were repeated in the final GSH session. Finally, to examine any longer-term 
impact of GSH upon mental health and social functioning, participants were sent the 




Power calculations were based on alpha set at α = .05, power = .80, and anticipated 
medium effect sizes. A medium effect size (around d = 0.4) was assumed based on effect 




sizes from similar studies or meta-analyses, ranging from d = 0.19 (Mead et al., 2005) to 
d = 0.80 (Gellatly et al., 2007). To detect differences between the intervention and 
control phases, paired samples t-tests were used and published power tables (Cohen, 
1992) indicated a sample size of 64 was required. Multiple regression was used to 
explore the effect of therapeutic alliance, self-efficacy and socio-economic status on 
outcomes following GSH. To detect a medium effect size (f² = 0.15) for three predictor 
variables in multiple regression analyses, published power tables (Cohen) indicated that 
a sample size of 76 would be required.  
 
Results 
General and demographic information  
Of 598 people invited to participate, 100 (16.7 per cent) opted-in, three of whom were 
excluded as they were subsequently assessed to be inappropriate for GSH. Of the 97 
people remaining, 72 (74.2 per cent) were female and ages ranged from 19 to 76 (M = 
36.8; SD = 12.5). Of these 97 participants, 37 (38 per cent) defaulted treatment: 20 
dropped out prior to the first GSH session and 17 defaulted after attending the first GSH 
session but prior to the final session. The remaining 60 participants completed the GSH 
intervention; 42 (70 per cent) of whom were female and ages ranged from 20 to 76 (M = 
37.2; SD = 12.3). Thirty-two presented primarily with anxiety-related problems, while 
the remainder presented with depressive-related problems. Twenty-five participants 
received their GSH intervention across three sessions, while 35 received their 
intervention across four sessions. The mean duration of the baseline control period was 
26.3 days (SD = 23.9) and 59.6 days (SD = 29.8) for the intervention period. At the time 




of analysis, three-month and six-month follow-up data were available for 25 and 16 
participants respectively. 
 
Effectiveness of GSH for anxiety and depression 
 
The mean outcome scores for completers on the HADS and WSAS across the five time-
points: pre-intervention (T1); intervention-start (T2); intervention-end (T3); three-month 
follow-up (T4); and six-month follow-up (T5), are displayed in Table 1. Values were not 
imputed for missing data (e.g., where a questionnaire had mistakenly been overlooked 
by a participant); rather, to conservatively assess effectiveness and ensure transparency 
across the time-points, data were only analysed for each participant where measurements 
had been obtained at T1, T2, and T3. 
Table 1 Anxiety, depression and functioning outcomes across time 
 
 HADS - Anxiety HADS - Depression WSAS 
 M SD n M SD n M SD n 
          
Pre (T1) 12.42 3.05   57* 8.16 3.83 57 19.64 7.01    44** 
          
Start (T2) 11.88 3.71 57 7.93 3.80 57 19.84 7.32 44 
          
End (T3)   8.19 3.28 57 4.74 3.00 57 14.77 7.78 44 
          
3-month (T4)    8.16 4.31 25 4.24 2.95 25 13.57 8.02 21 
          
6-month (T5)   9.44 3.37 16 5.06 3.55 16 14.00 7.92 14 
* Not complete HADS data across T1, T2, and T3 for n = 3, so removed from analysis.  
** Not complete WSAS data across T1, T2, and T3 for n = 16, so removed from analysis. 
 
 To ascertain whether these apparent improvements in mental health and social 
functioning across intervention and follow-up were significant compared to the control 
period, analyses examined whether symptom improvement by intervention-end (i.e., T3 




– T2), 3-month (i.e., T4 – T2) and 6-month follow-up (i.e., T5 – T2) was significantly 
greater than any spontaneous improvement across the control period (i.e., T2 – T1). 
Therefore, paired t-tests were conducted to compare the degree of improvement by 
intervention-end, three-month and six-month follow-up to any degree of improvement 
across the control period (e.g., T3 – T2 versus T2 – T1). Table 2 displays the t and p 
values, as well as the effect size (Cohen’s d) for each comparison. Across all three 
outcome measures, participants’ outcomes improved significantly between the start and 
end of GSH intervention relative to the control period. These significant improvements 
relative to the control period were maintained at three-month follow-up. Despite a small 
sample size at six-month follow-up, improvement in work and social functioning was 
also maintained.  
Table 2 Improvement in anxiety, depression and functioning across the 
intervention and follow-up compared to the control period 
 Intervention-end 
versus control period 
3-month follow-up 
versus control period 
6-month follow-up 
versus control period 
 










n = 57 
t = 4.20 
p < .01 
d = 0.91 
 
n = 57 
t = 4.22 
p < .01 
d = 0.88 
 
n = 44 
t = 3.19 
p < .01 
d = 0.75 
 
n = 25 
t = 3.20 
p < .01 
d = 1.04 
 
n = 25 
t = 2.62 
p = .02 
d = 0.74 
 
n = 21 
t = 2.67 
p = .02 
d = 0.80 
n = 16 
t = 1.99 
p = .07 
d = 0.83 
 
n = 16 
t = 1.75 
p = .10 
d = 0.74 
 
n = 14 
t = 2.50 
p = .03 
d = 0.92 
 
 To conservatively assess GSH effectiveness as indicated above, intent-to-treat 
(ITT) analysis using the last-observation-carried-forward (LOCF) technique was used to 




include those people who opted-in to the research but did not complete the GSH 
intervention. Therefore, for those people who defaulted GSH by end of treatment (n = 
37), all pre-intervention or intervention-start scores were carried forward to post-
intervention. Similarly, for those completers who had missing data (e.g., where a 
questionnaire had been mistakenly overlooked by the participant), LOCF was used to 
include these participants in the analysis. ITT analysis was based on 97 people (60 
completers and 37 non-completers). Since the small sample size at follow-up would 
have resulted in ITT analyses at follow-up being based on estimation for the vast 
majority (74 per cent) of cases and therefore less meaningful, ITT analyses were 
conducted on post-intervention data only. Table 3 displays ITT mean and standard 
deviation statistics.  
Table 3 Anxiety, depression and functioning outcomes across time under ITT  
 HADS – Anxiety 
       (N = 97) 
HADS – Depression 
       (N = 97) 
      WSAS  
       (N = 91*) 
 M SD  M SD  M SD  
          
Pre (T1) 12.16 3.20  7.79 3.80  18.69 7.66  
          
Start (T2) 11.73 3.51  7.60 3.78  18.70 8.35  
          
End (T3) 9.41 3.71  5.65 3.54  15.47 8.67  
*N = 6 did not have WSAS data at pre-intervention or intervention start so could not be included via last-
observation-carried-forward technique 
 
As Table 3 conveys, under ITT, the mean scores for all three outcomes at the end of 
intervention (T3) are still improved compared to intervention-start (T2). To determine 
whether this improvement by post-intervention was significant compared to any 




spontaneous improvement across the control period, paired t-tests were conducted as 
displayed in Table 4.  
Table 4 ITT analysis of improvement in anxiety, depression and functioning 
across the intervention compared to the control period 
  Control Intervention    




  0.43 2.04 2.32 3.72 3.91 < .01 0.63 
HADS - 
Depression 
0.19 2.05 1.95 3.49 3.94 < .01 0.61 
Work/Social 
functioning 
-0.01 4.58 3.23 6.80 3.52 < .01 0.56 
  
The ITT analyses illustrate that even conservatively using the last-observation-carried-
forward technique to accommodate missing data, significant improvements in mental 
health and social functioning occurred across the duration of the intervention relative to 
control, as evidenced by moderate to large effect sizes. Therefore, under ITT conditions, 
mental health and social functioning outcomes are significantly improved at post-
intervention.  
 
Clinically significant change on HADS  
As HADS subscale scores ≥ 11 typically indicate clinically significant symptomatology, 
the data of the 60 completers were examined to gauge what proportion of individuals 
experienced a clinically significant change in their symptoms. Of 38 people with 
clinically significant symptoms of anxiety at the start of GSH, 27 (71 per cent) no longer 
had clinically significant symptoms by the end of GSH intervention. Six of 15 (40 per 




cent) people no longer had clinically significant symptomatology by 3-month follow-up, 
while 6 of 9 (67 per cent) continued to enjoy clinically significant improved anxiety 
symptoms at six months. Of 7 people with clinically significant symptoms of depression 
at the start of GSH, 6 (86 per cent) no longer had clinically significant symptoms by 
intervention-end.  
 
Factors influencing mental health and social functioning outcomes 
As indicated previously, improvements in mental health (HADS) and social functioning 
(WSAS) were represented by calculating the difference in outcome scores between 
intervention start and end (i.e., T3 – T2). For the completer sample only, correlation and 
regression analyses were conducted to explore any relationships between these 
‘improvement scores’ in mental health and social functioning, and self-efficacy, 
therapeutic alliance and socio-economic status. Significant correlations were found in 
the following instances: HADS (anxiety) improvement by intervention-end was 
inversely correlated with patient self-efficacy in the first GSH session (r = -.39, p < .01), 
positively correlated with patient self-efficacy in the final session (r = .36, p < .01), and 
positively correlated with patients’ perception of the therapeutic alliance in the first 
session (r = .27, p < .05). HADS (depression) improvement by intervention-end was 
inversely correlated with patient self-efficacy in the first session (r = -.34, p = .01) and 
positively correlated with therapists’ perception of the therapeutic alliance in the final 
session (r = .29, p < .03). Improvement in social functioning was not correlated with 
self-efficacy, therapeutic alliance or socio-economic status. 




 Multiple linear regression was conducted to further examine the relationships 
indicated by correlation analysis. Thus, for a regression model with improvement in 
anxiety by intervention-end as the dependent variable, three independent variables 
(patient self-efficacy in first session; patient self-efficacy in final session; therapeutic 
alliance in first session) were entered into a stepwise regression analysis. The regression 
model was significantly predictive of outcome: F(2, 50) = 23.68, p < .01, explaining 
48.6 per cent of variance in anxiety improvement. Two variables emerged as significant 
predictors: low patient self-efficacy as rated in the first GSH session (β = -.66, t = 5.89, 
p < .01) and high patient self-efficacy as rated in the final GSH session (β = .63, t = 5.69, 
p < .01). Collinearity statistics conveyed that these two predictors loaded on to different 
dimensions, indicating that there was no presence of multicollinearity in the regression 
model.  
 Regarding improvement in depressive symptoms by intervention-end, as guided 
by correlation analysis, patient self-efficacy in the first session and therapeutic alliance 
in the final session were entered into a stepwise regression analysis. The regression 
model was significantly predictive of outcome: F(2, 51) = 6.40, p < .01, explaining 20.1 
per cent of variance in depression improvement. Two variables emerged as significant 
predictors: therapeutic alliance as rated by the therapist in the final session (β = .30, t = 
2.37, p = .02) and low patient self-efficacy in the first GSH session (β = -.29, t = 2.30, p 
= .03). Again, collinearity statistics highlighted that these two predictors loaded on to 
different dimensions, indicating that there was no presence of multicollinearity in the 
regression model. 







Effectiveness of GSH for anxiety and depression 
 
Patients’ mental health and social functioning were significantly improved at post-
treatment following GSH intervention, as evidenced by large effect sizes. These large 
effect sizes are consistent with those found in a recent, large-scale cohort study 
evaluating low-intensity interventions such as GSH in two IAPT sites (Clark et al., 
2009). Significant improvements within the completer sample were also obtained within 
conservative intent-to-treat (ITT) conditions, although the ITT effect sizes were 
considerably more moderate as would be expected. In comparison to previous GSH 
studies, the post-treatment effect sizes obtained here under ITT are midway between the 
large post-treatment effect sizes typical of non-clinical GSH studies (e.g., Andersson et 
al., 2005; Furmark et al., 2009) and the small effect sizes typical of clinical GSH studies 
(e.g., Mead et al., 2005; Salkovskis, Rimes, Stephenson, Sacks, & Scott, 2006). 
However, the post-treatment effect size (ES) is comparable to the clinical-based study of 
Richards et al. (2003; d = 0.49) and the non-clinical based study of Warmerdam et al. 
(2008; d = 0.54). The current findings were also comparable with a recent pragmatic 
randomised controlled trial of GSH for anxiety and depression (d = 0.38; Lucock, Kirby, 
& Wainwright, 2011). Possible reasons for the higher effect sizes observed in the current 
study include: milder baseline symptomatology; different self-help manuals being 
differentially effective; and the lack of a distinct control group. 
 The apparent discrepancy between the current study and previous clinically-
representative studies may be due to the current study’s non-randomised design and lack 




of a distinct control group. Alternatively, it may be that the patients in the current study 
began with a milder level of symptomatology than other studies and were thus better-
placed to benefit from a low-intensity intervention such as GSH. Indeed, in contrast to 
the study of Mead et al. (2005) in which the baseline combined HADS mean score was 
25.26 (SD = 6.66), the corresponding score in the present study was 19.33 (SD = 6.06). 
Some previous GSH studies (e.g., Lovell et al., 2008; Mead et al.) have included 
individuals with moderate to severe anxiety or depression, which are likely to be less 
suited to a low intensity intervention such as GSH. 
 As effect sizes at follow-up within previous clinically-representative studies have 
generally been small, it had been hypothesised that any GSH effectiveness at post-
treatment would not be maintained at follow-up. Within the completer analysis, 
improvements in anxiety, depression and functioning appeared to be maintained at 3-
month follow-up. However, it should be noted that the sample size was substantially 
lower at follow-up and this is one potential reason for the apparent lack of effectiveness 
at six-month follow-up. It is also possible that GSH was not found to be effective for 
anxiety and depressive symptomatology at six months because it is an intervention 
which does not lead to enduring benefit in the longer term, however the small sample 
size makes this difficult to ascertain. Nonetheless, the suggested maintenance of 
improved symptomatology and functioning at three months is consistent with the idea of 
longer-term benefit indicated by Williams et al. (2008) who reported significant benefit 
(d = 0.42) of GSH versus treatment as usual in reducing depressive symptomatology at 
8-month follow-up within primary care. Effectiveness of GSH at follow-up may be 
heightened by the enduring format of GSH in which individuals are typically given more 




self-help workbooks to work through beyond post-completion of the intervention. 
Therefore, with the premise being that the intervention is still ‘active’ by virtue of the 
person being their ‘own therapist’ in working through their self-help workbooks, it is 
possible that ongoing learning and reflection, as well as their improved self-efficacy, 
may lead to continued effectiveness of GSH in the medium-term. However, the fact that 
ITT analyses were not reported here at follow-up compared to previous GSH RCTs 
(e.g., Mead et al., 2005; Salkovskis et al., 2006) could explain the more conservative 
findings of these RCTs relative to the current study.  
 
Factors influencing GSH outcomes 
Patient self-efficacy was predictive of both anxiety and depressive improvement across 
the duration of the intervention, suggesting that patients starting GSH with lower self-
efficacy were likely to benefit from GSH to a greater extent than those starting GSH 
with higher self-efficacy. It is possible that those with higher self-efficacy had milder 
initial symptomatology, thereby limiting the scope for greater improvement compared to 
those with low self-efficacy whose baseline symptomatology may have been more 
extensive. Alternatively, it may be an indicator of a pattern specific to guided self-help 
as opposed to ‘pure’ or non-guided self-help, in which lower self-efficacy facilitates 
greater mental health improvement in guided interventions. A plausible mechanism for 
such a relationship could be that a patient who has low self-efficacy is more likely to 
have an external locus of control, thereby identifying with the therapist as being the 
main agent of change. Therefore, within a guided intervention such as GSH, the 
patient’s expectancy of the therapist to enact change could enhance their engagement 




with the guided nature of the intervention, thereby maximising their progress across the 
intervention.  
 Finding that therapeutic alliance as rated by the therapist in the final GSH session 
was predictive of improvement in depressive symptoms was suggestive of the 
development of a positive therapeutic alliance being influential within a short time-
frame such as within GSH interventions. It is unclear why therapeutic alliance as rated 
by the therapist emerged as a significant predictor and why it was predictive specifically 
of improvement in depressive (as opposed to anxiety) symptoms. It is possible that the 
almost universal positive ratings of the therapeutic alliance by patients within the first 
and final sessions led to less distinction between therapeutic ratings, giving less scope 
for patients’ ratings to emerge as a predictive variable. Otherwise, it may be that 
therapeutic alliance as rated by the therapist was predictive only of depression 
improvement rather than anxiety improvement due to the benefits of a positive 
therapeutic alliance (e.g., empathy and a positive attachment; Bordin, 1979), directly 
countering symptoms more typical of depression (e.g., loneliness and social withdrawal. 
Additionally, it is possible that therapeutic alliance did not emerge as a significant 
predictor of anxiety improvement due to the key role of self-efficacy in that regard, as 
evidenced by the large proportion of variance explained by self-efficacy. Nonetheless, 
together the above findings provide useful evidence of the importance of therapeutic 
alliance in influencing GSH outcomes despite the brevity of the intervention. This 
evidence is consistent with a recent meta-analysis of comparative GSH and traditional 
psychotherapy studies in which the resultant equivalent effectiveness was interpreted as 




being indicative of the contact per se between therapist and patient being essential rather 
than the amount of contact (Cuipers, Donker, van Straten, Li, & Andersson, 2010). 
 The lack of any relationship between socio-economic status and improvements in 
outcome may underline its lack of influence in determining GSH effectiveness. This 
interpretation is consistent with the study of Keeley et al. (2002) in which practitioners 
who were surveyed believed that SES was not influential in determining self-help 
outcomes, but conflicts with a more recent study in which practitioners generally 
believed that SES would be an important factor in determining effectiveness (MacLeod 
et al., 2009). However, the lack of influence of SES may have been a reflection of the 
sample being relatively homogeneous. Of the 60 completers, 65 per cent were 
categorised within the highest social class, with a further 13 per cent in the second-
highest of the five social classes. Therefore, its lack of influence could be due to the 
relatively minimal variation in SES, thereby reducing its likelihood of predicting 
outcomes. 
  
Strengths and limitations 
With a tendency for GSH research to be suggestive of efficacy rather than effectiveness 
in terms of lacking external validity, the current research conducted across three 
different primary care services offers clinically-representative, practice-based evidence 
to add to the GSH evidence base. The current study also adds to the evidence base by 
investigating depression, anxiety and functioning outcomes, and by following up 
effectiveness outcomes beyond post-treatment.  




 However, the substantially lower numbers of participants at follow-up and 
consequent inability to perform ITT analyses at follow-up is a limitation. Also, the 
absence of a distinct control group in parallel with the intervention may have led to an 
overestimation of effectiveness, as may the longer duration of the intervention phase in 
comparison to the control phase. In addition, the homogeneity of socio-economic status 
across the sample has implications for the extent to which the current study is 
representative of the wider population accessing GSH services. The majority of 
completers being of higher SES necessarily limits our conclusions regarding the 
effectiveness of GSH for completers of lower SES and perhaps highlights an issue 
regarding the accessibility of GSH for individuals of lower SES. Such limitations are a 
feature of this type of clinically-representative research and this context needs to be 
acknowledged accordingly when considering the extent to which findings appear 
suggestive of GSH effectiveness. 
 In finding patient self-efficacy and therapeutic alliance to be influential in 
impacting upon GSH outcomes, the current study adds some insight to our 
understanding of who benefits from GSH (e.g., Lovell et al., 2008). Knowing that people 
who begin guided self-help with low self-efficacy can make significant improvements in 
both their mental health and self-efficacy indicates the role GSH can play in fostering 
the belief that a person can become the primary agent of change in dealing with their 
problems and life stressors. In addition, the apparent contribution of therapeutic alliance 
in influencing GSH outcomes, underlines the importance of considering common factors 
(e.g., the therapeutic relationship) as potential mechanisms of change even within brief 
psychotherapeutic interventions such as GSH. 





Implications for clinical practice and future research 
In the context of the wider literature, the present results add to the evidence base for the 
effectiveness of GSH for anxiety and depression within clinically-representative 
populations. The current results lend tentative support to the inclusion of GSH within the 
stepped-care service model, however the numerous methodological limitations may have 
led to an overestimation of GSH effectiveness. Despite differences between services in 
terms of manuals, therapist experience and professional qualifications, and intervention 
duration, finding that they were equally effective suggests that the generic format of 
GSH can be effective across diverse clinical settings. For the two services which had 
sufficient numbers to allow comparative analysis, the differences in intervention 
duration and number of GSH sessions were significant. As these services were equally 
as effective at post-treatment, this suggests that GSH may be best delivered over a 
shorter-time-frame (i.e., 4 to 5 weeks rather than 11 weeks) and a three-session 
intervention (rather than 4 sessions typical of Service B). In support of this, the 
effectiveness of GSH for anxiety and depression has recently been demonstrated in a ‘2 
+ 1’ GSH model, consisting of three sessions with a total duration of 150 minutes 
(Lucock et al., 2011). An equivalent duration and session frequency seemed to lead to 
effectiveness within Service A, suggesting that adopting these parameters more widely 
within the GSH service model could, importantly: a) ensure that patients receive and 
complete their GSH intervention sooner; b) allow the ongoing service throughput of 
patients to occur efficiently; and c) free up more service capacity to help meet the ever-
increasing demand for psychological therapies. 




 The potential range of factors non-specific to GSH which could have been 
explored in this study was much wider. For example, a survey of CBT practitioners 
identified that the majority regarded patient variables such as motivation and educational 
level as factors likely to facilitate self-help effectiveness (MacLeod et al., 2009). Ideally, 
future patient-based as well as practitioner-based research will add to the current patient-
based study in determining the relative influences of non-specific factors such as 
motivation and educational level versus patient self-efficacy and therapeutic alliance. As 
well as an increased focus upon the impact of patient factors on GSH, self-help manuals 
are becoming increasingly developed to ensure maximum readability, diversified to 
encompass different media (Martinez, Whitfield, Dafters, & Williams, 2008), and 
adapted to incorporate common factors such as therapeutic alliance and empathy 
(Richardson, Richards, & Barkham, 2010). Therefore, the greater potential for 
interaction between specific and non-specific factors will necessarily require a research 
focus which embraces their relative contribution in what makes GSH effective for 
whom. 
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Bilich et al. (2008) - ‘Minimal contact’ condition did not involve guidance – i.e. purely 
assessment & monitoring. 
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Carlbring et al. (2001) - ‘Minimal contact’ condition less than minimum criterion of 30 minutes of 
guidance. 
Carlbring et al. (2003) - ‘Minimal contact’ condition did not involve guidance. 
Christensen et al. (2004) - No assessment of a diagnosis or cut-off score to establish caseness. 
Christensen et al. (2006) - Self-help conditions did not involve guidance. 
Clarke et al. (2005) - ‘Minimal contact’ condition did not involve guidance. 
den Boer et al. (2007) - Intervention based on IPT as well as CBT. 
- Therapist contact greater than 3 hours (approximately 10 hours). 
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Appendix 3 Participant information sheet 
  
                                                                                                                    
Research Participant Information Sheet 
Study title: What helps people to benefit from guided self-help? 
Invitation 
You have recently been referred to the ……………….guided self-help service within NHS 
Lothian. There is a research study taking place in the guided self-help service, and you are 
invited to take part in it if you wish. Before you decide, it is important for you to understand why 
the research is being done and what it would involve. Please take time to read the following 
information carefully and discuss it with others if you wish. Please ask if there is anything that is 
not clear or if you would like more information. Please take enough time to decide whether or 
not you wish to take part. Thank you for reading this information sheet. 
 
Why are we doing this study? 
Many studies have suggested that self-help is a useful treatment for a range of mental health 
problems. However, few studies have looked at what factors may help people to benefit from 
guided self-help. Our study will see if any of the following factors can help people to benefit 
from guided self-help treatment: 
o Patient’s confidence in their own ability to solve problems and make changes 
o Degree of rapport between the patient and the guided self-help therapist 
o Patient’s level of employment  
 
Why have I been chosen? 
We are asking everyone who is referred to the guided self-help service to take part in this study. 
We are hoping to include 76 people in this study. 
 
Do I have to take part? 
No. You are under no obligation to take part. If you decide not to take part in the study or to 
withdraw, this will have no effect upon your treatment within the guided self-help service or any 
future treatment. However, if you do decide to take part, you are still free to withdraw from the 
study at any time without having to give a reason. We would suggest that you wait at least 24 
hours to decide on whether to take part in this study. 
What will happen to me if I take part in this research? 
If you do decide to take part, please keep this information sheet and please sign and return 
the enclosed consent form within the stamped, addressed envelope within two weeks of 
receiving this information. Please also complete and return the four short questionnaires in 
the same envelope. These questionnaires include the Hospital Anxiety and Depression Scale, 
the Work and Social Adjustment Scale and the General Self-Efficacy Scale, and several 
brief questions about your occupation. They should take no longer than 10 minutes in total 
to complete. You will be asked to complete these questionnaires again during your first and last 





with the guided self-help service. Copies of these questionnaires will also be sent in the post to 
you three months, six months and twelve months after your final appointment. You will receive 
a stamped, addressed envelope on each occasion, in order to send the questionnaires back. 
  
Also, in your first and final guided self-help appointment, you will be asked to complete the 
Working Alliance Inventory which should take no more than 5 minutes to complete. In the last 
appointment with your guided self-help therapist, the Client Satisfaction Questionnaire is 
routinely used to get feedback from you about your guided self-help treatment. Again, this 
should take no longer than 5 minutes to complete. 
 
Lastly, to get an idea of how the guided self-help service may impact upon your need to visit 
your GP regarding your mental health and your need for medication, you will be asked a few 
brief questions about this in your first appointment with your guided self-help therapist and three 
months after you have completed your guided self-help treatment. This information will also be 
examined in your GP records. Across the whole study, the total time of your involvement is 
likely to be around 60 minutes. 
 
What are the possible disadvantages and risks of taking part? 
Apart from the time it takes to fill in the questionnaires, there are no other disadvantages or risks 
in taking part. 
 
What are the possible benefits of taking part? 
Taking part in this research will not make any difference to the treatment you receive, or how 
much benefit you obtain from it. However, the information we get will hopefully be useful in 
helping us to learn what helps people to benefit from guided self-help treatment and to ensure we 
provide a service which is as effective as it can be. 
 
Will my information be kept confidential? 
Yes. Any information that is collected will be stored securely, and will remain confidential. Only 
the lead researcher involved in the running of this study will be allowed access to such 
information. If the study is presented or published, all identifying information will be removed 
so that no research participants can be identified. 
 
What will happen to the results of the research study? 
Once this study ends in August 2011, it is hoped that our findings will be published in an 
academic journal. If you indicate on the consent form that you would like a copy of the main 
findings from the study, I will be happy to send this to you. 
 
Who has reviewed the study? 
This research has been ethically reviewed and approved by the University of Edinburgh Ethics 
Committee and assessed by the South East Scotland Research Ethics Service as not requiring 
further ethical review. 
 
Contact for further information 
If you wish to discuss any aspect of this research, please contact Greig Coull, Trainee Clinical 
Psychologist at the Psychology Department, St John’s Hospital, on 01506 523615.  
Many thanks for taking the time to read this information sheet. 
 





Appendix 4 Participant consent form 
 
 
                                                                                                     
 
Research Participant Consent Form 
 
 
Study title: What helps people to benefit from guided self-help? 
 




- I confirm I have read and understood the attached ‘Research Participant    Yes      No 
 Information Sheet’. 
 
- I understand that my participation is voluntary and that I can withdraw    Yes    No 
from this study at any time, without having to give a reason, without my  
care or legal rights being affected. 
 
- I understand that any data regarding my participation within this study    Yes    No 
will be stored safely, securely, confidentially and will only be accessible 
to the Lead Researcher. 
 
- I consent to take part in this study.         Yes      No 
 




Signed  Print Name  Date  
 (patient signature)  (patient name)   
















Appendix 5 Hospital Anxiety and Depression Scale 
 
NAME_______________________  DATE________________ 
 
This questionnaire is designed to help us know more about how you feel.  Please read each item and place 
a tick in the box opposite the reply that comes closest to how you have been feeling in the past week. 
Don’t take too long over your replies: your immediate reaction to each item will probably be more 
accurate than a long thought out response. 
 
 




I feel tense or ‘wound up’:  I feel as if I am slowed down:  
    Most of the time      Nearly all the time  
    A lot of the time      Very often  
    Time to time, Occasionally      Sometimes  
    Not at all      Not at all  
    
I still enjoy the things I used to enjoy:  I get a sort of frightened feeling like ‘butterflies’ in the 
stomach: 
 
    Definitely as much      Not at all  
    Not quite so much      Occasionally  
    A little but it doesn’t worry me      Quite often  
    Not at all      Very often  
    
I get a sort of frightened feeling as if something 
awful is about to happen:  
 I have lost interest in my appearance:  
    Very definitely and quite badly      Definitely  
    Yes, but not too badly      I don’t take as much care as I should  
    A little, but it doesn’t worry me      I may not take quite as much care  
    Not at all      I take just as much care as ever  
    
I can laugh and see the funny side of things:  I feel restless as if I have to be on the move:  
    As much as I always could      Very much indeed  
    Not quite so much now      Quite a lot  
    Definitely not so much now      Not very much  
    Not at all      Not at all  
    
Worrying thoughts go through my mind:  I look forward with enjoyment to things:  
    A great deal of the time      As much as I ever did  
    A lot of the time      Rather less than I used to  
    From time to time, but not too often      Definitely less than I used to  
    Only occasionally      hardly at all  
    
I feel cheerful:  I get sudden feelings of panic:  
    Not at all      Very often indeed  
    Not often      Quite often  
    Sometimes      Not very often  
   Most of the time      Not at all  
    
I can sit at ease and feel relaxed:  I can enjoy a good book or radio or TV programme:  
    Definitely      Often  
    Usually      Sometimes  
    Not often      Not often  





Appendix 6 Work and Social Adjustment Scale 
 
People's problems sometimes affect their ability to do certain day-to-day tasks in their lives. To rate your 
problems look at each section and determine on the scale provided how much your problem impairs your 
ability to carry out the activity. 
 
 
1. WORK - If you are retired or choose not to have a job for reasons unrelated to your problem, please tick N/A (not 
applicable) 
 
0 1 2 3 4 5 6 7 8  N/A 
Not at all  Slightly  Definitely Markedly                 Very severely I cannot work 
 
 
2. HOME MANAGEMENT – Cleaning, tidying, shopping, cooking, looking after home/children, paying bills etc 
 
0 1 2 3 4 5 6 7 8 
Not at all  Slightly  Definitely Markedly  Very severely 
 
 
3. SOCIAL LEISURE ACTIVITIES - With other people, e.g. parties, pubs, outings, entertaining etc. 
 
0 1 2 3 4 5 6 7 8 
Not at all  Slightly  Definitely Markedly  Very severely 
 
 
4. PRIVATE LEISURE ACTIVITIES – Done alone, e.g. reading, gardening, sewing, hobbies, walking etc. 
 
0 1 2 3 4 5 6 7 8 
Not at all  Slightly  Definitely Markedly                 Very severely 
 
 
5. FAMILY AND RELATIONSHIPS – Form and maintain close relationships with others including the people that 
I live with 
 
0 1 2 3 4 5 6 7 8 





















Appendix 7 Generalised Self-efficacy Scale 
 
 
For each of the following statements, please indicate the extent to which you think it is 
true of you. Please circle one number for every statement. As these statements are all 
beliefs you might or might not hold about yourself, there are no right or wrong answers. 
 
1 = Not at all true 2 = Hardly true 3 = Moderately true 4 = Exactly true 
 
1 I can always manage to solve difficult problems if I try hard enough.  1  2  3  4 
2 
If someone opposes me, I can find the means and ways to get what I 
want.  
1  2  3  4 
3 It is easy for me to stick to my aims and accomplish my goals.  1  2  3  4 
4 I am confident that I could deal efficiently with unexpected events.  1  2  3  4 
5 
Thanks to my resourcefulness, I know how to handle unforeseen 
situations.  
1  2  3  4 
6 I can solve most problems if I invest the necessary effort.  1  2  3  4 
7 
I can remain calm when facing difficulties because I can rely on my 
coping abilities.  
1  2  3  4 
8 
When I am confronted with a problem, I can usually find several 
solutions.  
1  2  3  4 
9 If I am in trouble, I can usually think of a solution.  1  2  3  4 




















Appendix 8 Socio-economic status questionnaire 
 
As explained in the research information sheet that you received with this questionnaire*, we are 
interested in finding out what effect people’s level of employment may have in helping people to benefit 
from guided self-help. There are 4 brief questions below. Please tick just one box per question. 
Question 1: Employee or self-employed 
‘Do (did) you work as an employee or are (were) you self-employed?’ 
 
Employee  Self-employed with employees   
Self-employed/freelance without employees (go to Question 4)  
Question 2: Number of employees 
For employees: ‘How many people work (worked) for your employer at the place where you work 
(worked)?’…………… 
 
For self-employed: ‘How many people do (did) you employ?’ 
(Go to question 4 when you have completed this question.) 1 to 24  25 or more  
Question 3: Supervisory status 
‘Do (did) you supervise any other employees?’ (A supervisor or foreman is responsible for  
overseeing the work of other employees on a day-to-day basis.) Yes   No  
Question 4: Occupation 
Please tick one box to show which best describes the sort of work that you do.  
If you are not working now, please tick one box to show what you did in your last job. 
 
- Modern professional occupations such as: teacher; nurse; physiotherapist; social worker; welfare officer; 
artist; musician; police officer (sergeant or above); software designer…    
 
- Clerical and intermediate occupations such as: secretary; personal assistant; clerical worker; office clerk; 
call centre agent; nursing auxiliary; nursery nurse…      
 
- Senior managers or administrators (usually responsible for planning, organising and co–ordinating work, 
and for finance) such as: finance manager; chief executive…     
 
- Technical and craft occupations such as: motor mechanic; fitter; inspector; plumber; printer; tool-maker; 
electrician; gardener; train driver…        
 
- Semi–routine manual and service occupations such as: postal worker; machine operative; security guard; 
caretaker; farm worker; catering assistant; receptionist; sales assistant…   
 
- Routine manual and service occupations such as: HGV driver; van driver; cleaner; porter; packer; sewing 
machinist; messenger; labourer; waiter/waitress; bar staff…     
 
- Middle or junior managers such as: office manager; retail manager; bank manager; publican; restaurant 
manager; warehouse manager…        
 
- Traditional professional occupations such as: accountant; solicitor; medical practitioner; scientist; 
 civil/mechanical engineer…        





Appendix 9 Mental Health Utilisation questionnaire 
 
                                                                                                   
 
Dear Research Participant, 
 
Thank you for agreeing to participate in this research study. As I explained in the 
information sheet you received at the start of the research study, I would like to ask you 
a few brief questions about your contact with your GP regarding your mental health and 
your use of medication to treat anxiety or depression within the past three months. I 
appreciate that this may be difficult to remember, and if so, please can you give your 
best guess. Please find the questions outlined below and once you are finished if you 





Trainee Clinical Psychologist and Lead Researcher 
_______________________________________________________________________ 
 
1. Within the past 3 months, approximately how many times have you visited your GP  
 
mainly because of mental health problems (e.g., anxiety and/or depression)?.................... 
 
2. Within the past 3 months, have you consulted any other mental health professionals  
 
(e.g., community psychiatric nurse, psychiatrist, etc) regarding your mental health  
 
problems (and if so, how many times?)?................................................................. 
 
3. Within the past 3 months, have you had a prescription for any anti-depressant  
 
medication (e.g., citalopram, fluoxetine, seroxat, sertraline, venlafaxine, etc...)  
 
and if so, what is the medication and daily dosage?....................................................... 
 



































Appendix 13 British Journal of Clinical Psychology guidelines for authors 
The British Journal of Clinical Psychology publishes original contributions to scientific knowledge in 
clinical psychology. This includes descriptive comparisons, as well as studies of the assessment, aetiology 
and treatment of people with a wide range of psychological problems in all age groups and settings. The 
level of analysis of studies ranges from biological influences on individual behaviour through to studies of 
psychological interventions and treatments on individuals, dyads, families and groups, to investigations of 
the relationships between explicitly social and psychological levels of analysis. 
The following types of paper are invited: 
• Papers reporting original empirical investigations 
• Theoretical papers, provided that these are sufficiently related to the empirical data 
• Review articles which need not be exhaustive but which should give an interpretation of the state of the 
research in a given field and, where appropriate, identify its clinical implications 
• Brief reports and comments 
1. Circulation 
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors throughout 
the world. 
2. Length 
Papers should normally be no more than 5000 words (excluding abstract, reference list, tables and 
figures), although the Editor retains discretion to publish papers beyond this length in cases where the 
clear and concise expression of the scientific content requires greater length. 
3. Submission and reviewing 
All manuscripts must be submitted via http://www.editorialmanager.com/bjcp/. The Journal operates a 
policy of anonymous peer review. 
4. Manuscript requirements 
• Contributions must be typed in double spacing with wide margins. All sheets must be numbered. 
• Manuscripts should be preceded by a title page which includes a full list of authors and their affiliations, 
as well as the corresponding author's contact details. A template can be downloaded from here. 
• Tables should be typed in double spacing, each on a separate page with a self-explanatory title. Tables 
should be comprehensible without reference to the text. They should be placed at the end of the 
manuscript with their approximate locations indicated in the text. 
• Figures can be included at the end of the document or attached as separate files, carefully labelled in 





background patterns, lines and shading should be avoided. Captions should be listed on a separate sheet. 
The resolution of digital images must be at least 300 dpi. 
• For articles containing original scientific research, a structured abstract of up to 250 words should be 
included with the headings: Objectives, Design, Methods, Results, Conclusions. Review articles should 
use these headings: Purpose, Methods, Results, Conclusions. 
• For reference citations, please use APA style. Particular care should be taken to ensure that references 
are accurate and complete. Give all journal titles in full. 
• SI units must be used for all measurements, rounded off to practical values if appropriate, with the 
imperial equivalent in parentheses. 
• In normal circumstances, effect size should be incorporated. 
• Authors are requested to avoid the use of sexist language. 
• Authors are responsible for acquiring written permission to publish lengthy quotations, illustrations, etc. 
for which they do not own copyright. For guidelines on editorial style, please consult the APA Publication 
Manual published by the American Psychological Association. 
 
